{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T23:18:15Z","timestamp":1790464695068,"version":"4.1.0"},"reference-count":422,"publisher":"MDPI AG","issue":"10","license":[{"start":{"date-parts":[[2016,10,19]],"date-time":"2016-10-19T00:00:00Z","timestamp":1476835200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecules"],"abstract":"<jats:p>Malaria, leishmaniasis, Chagas disease, and human African trypanosomiasis continue to cause considerable suffering and death in developing countries. Current treatment options for these parasitic protozoal diseases generally have severe side effects, may be ineffective or unavailable, and resistance is emerging. There is a constant need to discover new chemotherapeutic agents for these parasitic infections, and natural products continue to serve as a potential source. This review presents molecular docking studies of potential phytochemicals that target key protein targets in Leishmania spp., Trypanosoma spp., and Plasmodium spp.<\/jats:p>","DOI":"10.3390\/molecules21101389","type":"journal-article","created":{"date-parts":[[2016,10,19]],"date-time":"2016-10-19T10:32:57Z","timestamp":1476873177000},"page":"1389","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":37,"title":["The Potential of Secondary Metabolites from Plants as Drugs or Leads against Protozoan Neglected Diseases\u2014Part III: In-Silico Molecular Docking Investigations"],"prefix":"10.3390","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8048-5137","authenticated-orcid":false,"given":"Ifedayo","family":"Ogungbe","sequence":"first","affiliation":[{"name":"Department of Chemistry and Biochemistry, Jackson State University, Jackson, MS 39217, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3639-0528","authenticated-orcid":false,"given":"William","family":"Setzer","sequence":"additional","affiliation":[{"name":"Department of Chemistry, University of Alabama in Huntsville, Huntsville, AL 35899, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2016,10,19]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/S0140-6736(12)60034-8","article-title":"Global malaria mortality between 1980 and 2010: A systematic analysis","volume":"379","author":"Murray","year":"2012","journal-title":"Lancet"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1016\/S0140-6736(10)60061-X","article-title":"Chagas disease","volume":"375","author":"Rassi","year":"2010","journal-title":"Lancet"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/S0140-6736(09)60829-1","article-title":"Human African trypanosomiasis","volume":"375","author":"Brun","year":"2010","journal-title":"Lancet"},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Alvar, J., V\u00e9lez, I.D., Bern, C., Herrero, M., Desjeux, P., Cano, J., Jannin, J., den Boer, M., and The WHO Leishmaniasis Control Team (2012). Leishmaniasis worldwide and global estimates of its incidence. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0035671"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/7355_2011_14","article-title":"Discovering new medicines to control and eradicate malaria","volume":"7","author":"Burrows","year":"2011","journal-title":"Top. Med. Chem."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1590\/S0074-02762002000100001","article-title":"A critical review on Chagas disease chemotherapy","volume":"97","author":"Coura","year":"2002","journal-title":"Mem. Inst. Oswaldo Cruz"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/j.pt.2003.09.002","article-title":"Chemotherapy of human African trypanosomiasis: Current and future prospects","volume":"19","author":"Fairlamb","year":"2003","journal-title":"Trends Parasitol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1111\/j.1469-0691.2011.03630.x","article-title":"Leishmaniasis chemotherapy\u2014Challenges and opportunities","volume":"17","author":"Croft","year":"2011","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1038\/nrd4510","article-title":"The re-emergence of natural products for drug discovery in the genomics era","volume":"14","author":"Harvey","year":"2015","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"2128","DOI":"10.2174\/092986712800229023","article-title":"The potential of secondary metabolites from plants as drugs or leads against protozoan neglected diseases\u2014Part I","volume":"19","author":"Schmidt","year":"2012","journal-title":"Curr. Med. Chem."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"2176","DOI":"10.2174\/092986712800229087","article-title":"The potential of secondary metabolites from plants as drugs or leads against protozoan neglected diseases\u2014Part II","volume":"19","author":"Schmidt","year":"2012","journal-title":"Curr. Med. Chem."},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"M\u00fcller, S., Cerdan, R., and Radulescu, O. (2016). Comprehensive Analysis of Parasite Biology: From Metabolism to Drug Discovery, Wiley-VCH.","DOI":"10.1002\/9783527694082"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1021\/jm801514w","article-title":"Novel chemical space exploration via natural products","volume":"52","author":"Gottfries","year":"2009","journal-title":"J. Med. Chem."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1021\/ci0200467","article-title":"Property distributions: Differences between drugs, natural products, and molecules from combinatorial chemistry","volume":"43","author":"Feher","year":"2003","journal-title":"J. Chem. Inform. Comput. Sci."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.cbpa.2008.03.016","article-title":"The impoact of natural products upon modern drug discovery","volume":"12","author":"Ganesan","year":"2008","journal-title":"Curr. Opin. Chem. Biol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.cbpa.2006.06.014","article-title":"A practical view of \u2018druggability\u2019","volume":"10","author":"Keller","year":"2006","journal-title":"Curr. Opin. Chem. Biol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1021\/np200906s","article-title":"Natural products as sources of new drugs over the 30 years from 1981 to 2010","volume":"75","author":"Newman","year":"2012","journal-title":"J. Nat. Prod."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"3533","DOI":"10.1093\/emboj\/18.13.3533","article-title":"Crystal structures of adenine phosphoribosyltransferase from Leishmania donovani","volume":"18","author":"Phillips","year":"1999","journal-title":"EMBO J."},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Kuettel, S., Greenwald, J., Kostrewa, D., Ahmed, S., Scapozza, L., and Perozzo, R. (2011). Crystal structures of T. b. rhodesiense adenosine kinase complexed with inhibitor and activator: Implications for catalysis and hyperactivation. PLoS Negl. Trop. Dis., 5.","DOI":"10.2210\/pdb3otx\/pdb"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1107\/S2053230X13033621","article-title":"Structures of adenosine kinase from Trypanosoma brucei brucei","volume":"70","author":"Timm","year":"2014","journal-title":"Acta Crystallogr. F Struct. Biol. Commun."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1016\/j.jmb.2003.11.036","article-title":"Crystal structure of fully ligated adenylosuccinate synthetase from Plasmodium falciparum","volume":"335","author":"Eaazhisai","year":"2004","journal-title":"J. Mol. Biol."},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Wernimont, A.K., Osman, K.T., Loppnau, P., Arrowsmith, C.H., Edwards, A.M., Bountra, C., Hui, R., and Lin, Y.H. (2012). Crystal Structure of an M17 aminopeptidase from Trypanosoma brucei, Tb427tmp.02.4440, doi:10.2210\/pdb4efd\/pdb.","DOI":"10.2210\/pdb4efd\/pdb"},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Vulliez-Le Normand, B., Tonkin, M.L., Lamarque, M.H., Langer, S., Hoos, S., Roques, M., Saul, F.A., Faber, B.W., Bentley, G.A., and Boulanger, M.J. (2012). Structural and functional insights into the malaria parasite moving junction complex. PLoS Pathog., 8.","DOI":"10.1371\/journal.ppat.1002755"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.abb.2013.03.015","article-title":"Crystal structure of arginase from Leishmania mexicana and implications for the inhibition of polyamine biosynthesis in parasitic infections","volume":"535","author":"Ullman","year":"2013","journal-title":"Arch. Biochem. Biophys."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"5600","DOI":"10.1021\/bi100390z","article-title":"Crystal structure of arginase from Plasmodium falciparum and implications for l-arginine depletion in malarial infection","volume":"49","author":"Dowling","year":"2010","journal-title":"Biochemistry"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"5432","DOI":"10.1021\/jm200443b","article-title":"Binding of \u03b1,\u03b1-disubstituted amino acids to arginase suggests new avenues for inhibitor design","volume":"54","author":"Ilies","year":"2011","journal-title":"J. Med. Chem."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1002\/prot.21557","article-title":"The crystal structure of Trypanosoma cruzi arginine kinase","volume":"69","author":"Fernandez","year":"2007","journal-title":"Proteins"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/j.jmb.2010.11.018","article-title":"Specific inhibition of the aspartate aminotransferase of Plasmodium falciparum","volume":"405","author":"Wrenger","year":"2011","journal-title":"J. Mol. Biol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.jsb.2012.09.001","article-title":"Structural characterization and inhibition of the Plasmodium Atg8-Atg3 interaction","volume":"180","author":"Hain","year":"2012","journal-title":"J. Struct. Biol."},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Kerr, I.D., Wu, P., Marion-Tsukamaki, R., Mackey, Z.B., and Brinen, L.S. (2010). Crystal Structures of TbCatB and rhodesain, potential chemotherapeutic targets and major cysteine proteases of Trypanosoma brucei. PLoS Negl. Trop. Dis., 4.","DOI":"10.1371\/journal.pntd.0000701"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/nmeth.1859","article-title":"In vivo protein crystallization opens new routes in structural biology","volume":"9","author":"Koopmann","year":"2012","journal-title":"Nat. Methods"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1126\/science.1229663","article-title":"Natively inhibited Trypanosoma brucei cathepsin B structure determined by using an X-ray laser","volume":"339","author":"Redecke","year":"2013","journal-title":"Science"},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Wernimont, A.K., Pizarro, J.C., Artz, J.D., Amaya, M.F., Xiao, T., Lew, J., Wasney, G., Senesterra, G., Kozieradzki, I., and Cossar, D. (2009). Crystal structure of choline kinase from Plasmodium Falciparum, PF14_0020, doi:10.2210\/pdb3fi8\/pdb.","DOI":"10.2210\/pdb3fi8\/pdb"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1002\/pro.5560060801","article-title":"Structural determinants of specificity in the cysteine protease cruzain","volume":"6","author":"Gillmor","year":"1997","journal-title":"Protein Sci."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/S0969-2126(00)00173-8","article-title":"A target within the target: Probing cruzain\u2019s P1\u2019 site to define structural determinants for the Chagas\u2019 disease protease","volume":"8","author":"Brinen","year":"2000","journal-title":"Structure"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0968-0896(02)00427-3","article-title":"Crystal structures of reversible ketone-based inhibitors of the cysteine protease cruzain","volume":"11","author":"Huang","year":"2003","journal-title":"Bioorg. Med. Chem."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.1016\/j.bmc.2004.12.053","article-title":"Development of \u03b1-keto-based inhibitors of cruzain, a cysteine protease implicated in Chagas disease","volume":"13","author":"Choe","year":"2005","journal-title":"Bioorg. Med. Chem."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"25697","DOI":"10.1074\/jbc.M109.014340","article-title":"Vinyl sulfones as antiparasitic agents and a structural basis for drug design","volume":"284","author":"Kerr","year":"2009","journal-title":"J. Biol. Chem."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"6218","DOI":"10.1016\/j.bmcl.2009.08.098","article-title":"Novel non-peptidic vinylsulfones targeting the S2 and S3 subsites of parasite cysteine proteases","volume":"19","author":"Bryant","year":"2009","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1021\/jm901069a","article-title":"Identification and optimization of inhibitors of Trypanosomal cysteine proteases: Cruzain, rhodesain, and TbCatB","volume":"53","author":"Mott","year":"2010","journal-title":"J. Med. Chem."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1021\/jm901633v","article-title":"Nonpeptidic tetrafluorophenoxymethyl ketone cruzain inhibitors as promising new leads for Chagas disease chemotherapy","volume":"53","author":"Brak","year":"2010","journal-title":"J. Med. Chem."},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"Chen, Y.T., Brinen, L.S., Kerr, I.D., Hansell, E., Doyle, P.S., McKerrow, J.H., and Roush, W.R. (2010). In vitro and in vivo studies of the trypanocidal properties of WRR-483 against Trypanosoma cruzi. PLoS Negl. Trop. Dis., 4.","DOI":"10.1371\/journal.pntd.0000825"},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Wiggers, H.J., Rocha, J.R., Fernandes, W.B., Sesti-Costa, R., Carneiro, Z.A., Cheleski, J., da Silva, A.B., Juliano, L., Cezari, M.H., and Silva, J.S. (2013). Non-peptidic cruzain inhibitors with trypanocidal activity discovered by virtual screening and in vitro assay. PLoS Negl. Trop. Dis., 7.","DOI":"10.1371\/journal.pntd.0002370"},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"Brinen, L.S., Gillmor, S.A., and Fletterick, R.J. (2003). Crystal structures of cruzain bound to three different substrates, doi:10.2210\/pdb1ewl\/pdb, doi:10.2210\/pdb1ewm\/pdb, doi:10.2210\/pdb1ewo\/pdb.","DOI":"10.2210\/pdb1ewl\/pdb"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1107\/S0907444909034234","article-title":"Structure of cyclophilin from Leishmania donovani bound to cyclosporin at 2.6 \u00c5 resolution: Correlation between structure and thermodynamic data","volume":"65","author":"Venugopal","year":"2009","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"ref_46","doi-asserted-by":"crossref","unstructured":"Arakaki, T.L., and Merritt, E.A. (2006). Cyclophilin from Leishmania major, doi:10.2210\/pdb2hqj\/pdb.","DOI":"10.2210\/pdb2hqj\/pdb"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1006\/jmbi.2000.3633","article-title":"The three-dimensional structure of a Plasmodium falciparum cyclophilin in complex with the potent anti-malarial cyclosporin A","volume":"298","author":"Peterson","year":"2000","journal-title":"J. Mol. Biol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1107\/S1744309112019124","article-title":"Structure of Leishmania major cysteine synthase","volume":"68","author":"Fyfe","year":"2012","journal-title":"Acta Crystallogr. Sect. F Struct. Biol. Cryst. Commun."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"16470","DOI":"10.1074\/jbc.M111.224873","article-title":"The crystal structure of the Leishmania major deoxyuridine triphosphate nucleotidohydrolase in complex with nucleotide analogues, dUMP, and deoxyuridine","volume":"286","author":"Hemsworth","year":"2011","journal-title":"J. Biol. Chem."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.str.2004.11.015","article-title":"dUTPase as a platform for antimalarial drug design: Structural basis for the selectivity of a class of nucleoside inhibitors","volume":"13","author":"Whittingham","year":"2005","journal-title":"Structure"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"2378","DOI":"10.1016\/j.bmc.2011.02.012","article-title":"\u03b2-Branched acyclic nucleoside analogues as inhibitors of Plasmodium falciparum dUTPase","volume":"19","author":"McCarthy","year":"2011","journal-title":"Bioorg. Med. Chem."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1002\/cmdc.201100255","article-title":"Design, synthesis, and evaluation of 5\u2032-diphenyl nucleoside analogues as inhibitors of the Plasmodium falciparum dUTPase","volume":"6","author":"Hampton","year":"2011","journal-title":"ChemMedChem"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1042\/BJ20130796","article-title":"On the catalytic mechanism of dimeric dUTPases","volume":"456","author":"Hemsworth","year":"2013","journal-title":"Biochem. J."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.str.2003.11.016","article-title":"The crystal structure of Trypanosoma cruzi dUTPase reveals a novel dUTP\/dUDP binding fold","volume":"12","author":"Harkiolaki","year":"2004","journal-title":"Structure"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s10969-007-9036-1","article-title":"Structural genomics of protein phosphatases","volume":"8","author":"Almo","year":"2007","journal-title":"J. Struct. Funct. Genom."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1038\/nsb921","article-title":"Insights into antifolate resistance from malarial DHFR-TS structures","volume":"10","author":"Yuvaniyama","year":"2003","journal-title":"Nat. Struct. Biol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1021\/cb8002804","article-title":"Exploiting structural analysis, in silico screening, and serendipity to identify novel inhibitors of drug-resistant falciparum malaria","volume":"4","author":"Dasgupta","year":"2009","journal-title":"ACS Chem. Biol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1021\/cb200124r","article-title":"Trypanosomal dihydrofolate reductase reveals natural antifolate resistance","volume":"6","author":"Vanichtanankul","year":"2011","journal-title":"ACS Chem. Biol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"3928","DOI":"10.1128\/AAC.00301-12","article-title":"Combined spatial limitation around residues 16 and 108 of Plasmodium falciparum dihydrofolate reductase explains resistance to cycloguanil","volume":"56","author":"Vanichtanankul","year":"2012","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"16823","DOI":"10.1073\/pnas.1204556109","article-title":"Malarial dihydrofolate reductase as a paradigm for drug development against a resistance-compromised target","volume":"109","author":"Yuthavong","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1002\/prot.22115","article-title":"Structure-based approach to pharmacophore identification, in silico screening, and three-dimensional quantitative structure-activity relationship studies for inhibitors of Trypanosoma cruzi dihydrofolate reductase function","volume":"73","author":"Schormann","year":"2008","journal-title":"Proteins"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1107\/S090744490901230X","article-title":"Structures of dihydrofolate reductase-thymidylate synthase of Trypanosoma cruzi in the folate-free state and in complex with two antifolate drugs, trimetrexate and methotrexate","volume":"65","author":"Senkovich","year":"2009","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"4056","DOI":"10.1016\/j.bmc.2010.04.020","article-title":"Synthesis and characterization of potent inhibitors of Trypanosoma cruzi dihydrofolate reductase","volume":"18","author":"Schormann","year":"2010","journal-title":"Bioorg. Med. Chem."},{"key":"ref_64","doi-asserted-by":"crossref","unstructured":"Arakaki, T.L., Merritt, E.A., Ullman, B., and Yates, P.A. (2008). Crystal structure of dihydroorotate dehydrogenase from Leishmania donovani, doi:10.2210\/pdb3c61\/pdb.","DOI":"10.2210\/pdb3c61\/pdb"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"5899","DOI":"10.1016\/j.ejmech.2010.09.055","article-title":"Novel insights for dihydroorotate dehydrogenase class 1A inhibitors discovery","volume":"45","author":"Cheleski","year":"2010","journal-title":"Eur. J. Med. Chem."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1016\/j.biochi.2012.04.003","article-title":"Crystal structure of dihydroorotate dehydrogenase from Leishmania major","volume":"94","author":"Cordeiro","year":"2012","journal-title":"Biochimie"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"2615","DOI":"10.2174\/1381612811319140011","article-title":"Target sites for the design of anti-trypanosomatid drugs based on the structure of dihydroorotate dehydrogenase","volume":"19","author":"Pinheiro","year":"2013","journal-title":"Curr. Pharm. Des."},{"key":"ref_68","doi-asserted-by":"crossref","unstructured":"Cordeiro, A.T., Feliciano, P.R., and Nonato, M.C. (2010). Crystal structure of Leishmania major dihydroorotate dehydrogenase, doi:10.2210\/pdb3gye\/pdb, doi:10.2210\/pdb3gz3\/pdb.","DOI":"10.2210\/pdb3gz3\/pdb"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1107\/S0907444905042642","article-title":"Structure of Plasmodium falciparum dihydroorotate dehydrogenase with a bound inhibitor","volume":"62","author":"Hurt","year":"2006","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"26999","DOI":"10.1074\/jbc.M109.028589","article-title":"Structural plasticity of malaria dihydroorotate dehydrogenase allows selective binding of diverse chemical scaffolds","volume":"284","author":"Deng","year":"2009","journal-title":"J. Biol. Chem."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"33054","DOI":"10.1074\/jbc.M110.162081","article-title":"Novel inhibitors of Plasmodium falciparum dihydroorotate dehydrogenase with anti-malarial activity in the mouse model","volume":"285","author":"Booker","year":"2010","journal-title":"J. Biol. Chem."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"5540","DOI":"10.1021\/jm200592f","article-title":"Structure-guided lead optimization of triazolopyrimidine-ring substituents identifies potent Plasmodium falciparum dihydroorotate dehydrogenase inhibitors with clinical candidate potential","volume":"54","author":"Coteron","year":"2011","journal-title":"J. Med. Chem."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"17980","DOI":"10.1074\/jbc.M114.558353","article-title":"In vitro resistance selections for Plasmodium falciparum dihydroorotate dehydrogenase inhibitors give mutants with multiple point mutations in the drug-binding site and altered growth","volume":"289","author":"Ross","year":"2014","journal-title":"J. Biol. Chem."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1111\/j.1365-2958.2008.06131.x","article-title":"Characterization of Trypanosoma brucei dihydroorotate dehydrogenase as a possible drug target; structural, kinetic and RNAi studies","volume":"68","author":"Arakaki","year":"2008","journal-title":"Mol. Microbiol."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/j.bbrc.2008.02.074","article-title":"Crystal structure of Trypanosoma cruzi dihydroorotate dehydrogenase from Y strain","volume":"369","author":"Pinheiro","year":"2008","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"10881","DOI":"10.1021\/bi800413r","article-title":"Structures of Trypanosoma cruzi dihydroorotate dehydrogenase complexed with substrates and products: Atomic resolution insights into mechanisms of dihydroorotate oxidation and fumarate reduction","volume":"47","author":"Inaoka","year":"2008","journal-title":"Biochemistry"},{"key":"ref_77","doi-asserted-by":"crossref","unstructured":"Inaoka, D.K., Shimizu, H., Sakamoto, K., Shiba, T., Kurisu, G., Nara, T., Aoki, T., Harada, S., and Kita, K. (2008). Crystal structures of Trypanosoma cruzi dihydroorotate dehydrogenase, doi:10.2210\/pdb2e68\/pdb, doi:10.2210\/pdb2e6a\/pdb, doi:10.2210\/pdb2e6f\/pdb, doi:10.2210\/pdb2djl\/pdb, doi:10.2210\/pdb2djx\/pdb.","DOI":"10.2210\/pdb2e6f\/pdb"},{"key":"ref_78","doi-asserted-by":"crossref","unstructured":"Inaoka, D.K., Iida, M., Tabuchi, T., Lee, N., Matsuoka, S., Shiba, T., Sakamoto, K., Suzuki, S., Balogun, E.O., and Nara, T. (2013). Structures of Trypanosoma cruzi dihydroorotate dehydrogenase, doi:10.2210\/pdb3w1a\/pdb, doi:10.2210\/pdb3w1l\/pdb, doi:10.2210\/pdb3w1m\/pdb, doi:10.2210\/pdb3w1n\/pdb, doi:10.2210\/pdb3w1p\/pdb, doi:10.2210\/pdb3w1q\/pdb, doi:10.2210\/pdb3w1r\/pdb, doi:10.2210\/pdb3w1t\/pdb, doi:10.2210\/pdb3w1ut\/pdb, doi:10.2210\/pdb3w1x\/pdb, doi:10.2210\/pdb3w22\/pdb, doi:10.2210\/pdb3w23\/pdb, doi:10.2210\/pdb3w2j\/pdb, doi:10.2210\/pdb3w2k\/pdb, doi:10.2210\/pdb3w2l\/pdb, doi:10.2210\/pdb3w2m\/pdb, doi:10.2210\/pdb3w2n\/pdb, doi:10.2210\/pdb3w2u\/pdb.","DOI":"10.2210\/pdb3w2m\/pdb"},{"key":"ref_79","doi-asserted-by":"crossref","unstructured":"Inaoka, D.K., Iida, M., Tabuchi, T., Lee, N., Matsuoka, S., Shiba, T., Sakamoto, K., Suzuki, S., Rocha, J.R., and Balogun, E.O. (2014). Structure of Trypanosoma cruzi dihydroorotate dehydrogenase in complex with MII-4-053, doi:10.2210\/pdb3w3o\/pdb.","DOI":"10.2210\/pdb3w3o\/pdb"},{"key":"ref_80","doi-asserted-by":"crossref","unstructured":"Inaoka, D.K., Iida, M., Tabuchi, T., Lee, N., Hashimoto, S., Matsuoka, S., Kuranaga, T., Shiba, T., Sakamoto, K., and Suzuki, S. (2014). Structures of Trypanosoma cruzi dihydroorotate dehydrogenase, doi:10.2210\/pdb3w6y\/pdb, doi:10.2210\/pdb3w70\/pdb, doi:10.2210\/pdb3w71\/pdb, doi:10.2210\/pdb3w72\/pdb, doi:10.2210\/pdb3w73\/pdb, doi:10.2210\/pdb3w74\/pdb, doi:10.2210\/pdb3w75\/pdb, doi:10.2210\/pdb3w76\/pdb, doi:10.2210\/pdb3w7c\/pdb, doi:10.2210\/pdb3w7d\/pdb, doi:10.2210\/pdb3w7e\/pdb, doi:10.2210\/pdb3w7g\/pdb, doi:10.2210\/pdb3w7h\/pdb, doi:10.2210\/pdb3w7i\/pdb, doi:10.2210\/pdb3w7j\/pdb, doi:10.2210\/pdb3w7k\/pdb, doi:10.2210\/pdb3w7l\/pdb, doi:10.2210\/pdb3w7m\/pdb, doi:10.2210\/pdb3w7n\/pdb, doi:10.2210\/pdb3w7o\/pdb, doi:10.2210\/pdb3w7p\/pdb, doi:10.2210\/pdb3w7q\/pdb, doi:10.2210\/pdb4jd4\/pdb, doi:10.2210\/pdb4jdb\/pdb.","DOI":"10.2210\/pdb3w7q\/pdb"},{"key":"ref_81","doi-asserted-by":"crossref","unstructured":"Inaoka, D.K., Iida, M., Tabuchi, T., Lee, N., Hashimoto, S., Matsuoka, S., Kuranaga, T., Shiba, T., Sakamoto, K., and Suzuki, S. (2014). Structures of Trypanosoma cruzi dihydroorotate dehydrogenase, doi:10.2210\/pdb3w83\/pdb, doi:10.2210\/pdb3w84\/pdb, doi:10.2210\/pdb3w85\/pdb.","DOI":"10.2210\/pdb3w83\/pdb"},{"key":"ref_82","doi-asserted-by":"crossref","unstructured":"Inaoka, D.K., Hashimoto, S., Rocha, J.R., Iida, M., Tabuchi, T., Lee, N., Matsuoka, S., Kuranaga, T., Shiba, T., and Balogun, E.O. (2014). Structures of Trypanosoma cruzi dihydroorotate dehydrogenase, doi:10.2210\/pdb3w86\/pdb, doi:10.2210\/pdb3w87\/pdb, doi:10.2210\/pdb3w88\/pdb.","DOI":"10.2210\/pdb3w86\/pdb"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"5917","DOI":"10.1074\/jbc.M109.038562","article-title":"Ligand-bound structures provide atomic snapshots for the catalytic mechanism of D-amino acid deacylase","volume":"285","author":"Bhatt","year":"2010","journal-title":"J. Biol. Chem."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1107\/S0907444910006062","article-title":"Structure of d-tyrosyl-tRNATyr deacylase using home-source Cu Kalpha and moderate-quality iodide-SAD data: Structural polymorphism and HEPES-bound enzyme states","volume":"66","author":"Yogavel","year":"2010","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"e01519","DOI":"10.7554\/eLife.01519","article-title":"Mechanism of chiral proofreading during translation of the genetic code","volume":"2","author":"Ahmad","year":"2013","journal-title":"Elife"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/S0022-2836(03)00752-6","article-title":"The crystal structure of Trypanosoma brucei enolase: Visualisation of the inhibitory metal binding site III and potential as target for selective, irreversible inhibition","volume":"331","author":"Hannaert","year":"2003","journal-title":"J. Mol. Biol."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"5077","DOI":"10.1111\/j.1742-4658.2007.06027.x","article-title":"Structural flexibility in Trypanosoma brucei enolase revealed by X-ray crystallography and molecular dynamics","volume":"274","author":"Mello","year":"2007","journal-title":"FEBS J."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"13106","DOI":"10.1074\/jbc.M112000200","article-title":"Structural elucidation of the specificity of the antibacterial agent triclosan for malarial enoyl acyl carrier protein reductase","volume":"277","author":"Perozzo","year":"2002","journal-title":"J. Biol. Chem."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.jmb.2004.08.033","article-title":"Structural basis for the variation in triclosan affinity to enoyl reductases","volume":"343","author":"Pidugu","year":"2004","journal-title":"J. Mol. Biol."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"5247","DOI":"10.1016\/j.bmcl.2005.08.044","article-title":"Synthesis, biological activity, and X-ray crystal structural analysis of diaryl ether inhibitors of malarial enoyl acyl carrier protein reductase. Part 1: 4\u2032-substituted triclosan derivatives","volume":"15","author":"Freundlich","year":"2005","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1107\/S0907444906053625","article-title":"Studies of Toxoplasma gondii and Plasmodium falciparum enoyl acyl carrier protein reductase and implications for the development of antiparasitic agents","volume":"63","author":"Muench","year":"2007","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"25436","DOI":"10.1074\/jbc.M701813200","article-title":"X-ray structural analysis of Plasmodium falciparum enoyl acyl carrier protein reductase as a pathway toward the optimization of triclosan antimalarial efficacy","volume":"282","author":"Freundlich","year":"2007","journal-title":"J. Biol. Chem."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1002\/iub.327","article-title":"X-ray crystallographic analysis of the complexes of enoyl acyl carrier protein reductase of Plasmodium falciparum with triclosan variants to elucidate the importance of different functional groups in enzyme inhibition","volume":"62","author":"Maity","year":"2010","journal-title":"IUBMB Life"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"7516","DOI":"10.1021\/jm400637m","article-title":"Design, synthesis, and biological and crystallographic evaluation of novel inhibitors of Plasmodium falciparum enoyl-ACP-reductase (PfFabI)","volume":"56","author":"Belluti","year":"2013","journal-title":"J. Med. Chem."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"11503","DOI":"10.1073\/pnas.0600489103","article-title":"Structural basis for unique mechanisms of folding and hemoglobin binding by a malarial protease","volume":"103","author":"Wang","year":"2006","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"25425","DOI":"10.1074\/jbc.M603776200","article-title":"Structural and functional characterization of Falcipain-2, a hemoglobinase from the malarial parasite Plasmodium falciparum","volume":"281","author":"Hogg","year":"2006","journal-title":"J. Biol. Chem."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.str.2007.03.012","article-title":"The structure of chagasin in complex with a cysteine protease clarifies the binding mode and evolution of an inhibitor family","volume":"15","author":"Wang","year":"2007","journal-title":"Structure"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1021\/jm8013663","article-title":"Structures of falcipain-2 and falcipain-3 bound to small molecule inhibitors: Implications for substrate specificity","volume":"52","author":"Kerr","year":"2009","journal-title":"J. Med. Chem."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/j.str.2011.03.025","article-title":"Structural basis for the regulation of cysteine-protease activity by a new class of protease inhibitors in Plasmodium","volume":"19","author":"Hansen","year":"2011","journal-title":"Structure"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1107\/S1399004713033221","article-title":"Structural and thermodynamic basis of the inhibition of Leishmania major farnesyl diphosphate synthase by nitrogen-containing bisphosphonates","volume":"70","author":"Aripirala","year":"2014","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"14485","DOI":"10.1021\/ja061737c","article-title":"Solid-state NMR, crystallographic, and computational investigation of bisphosphonates and farnesyl diphosphate synthase-bisphosphonate complexes","volume":"128","author":"Mao","year":"2006","journal-title":"J. Am. Chem. Soc."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1002\/prot.22066","article-title":"Structures of a potent phenylalkyl bisphosphonate inhibitor bound to farnesyl and geranylgeranyl diphosphate synthases","volume":"73","author":"Cao","year":"2008","journal-title":"Proteins"},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"5153","DOI":"10.1021\/ja808285e","article-title":"Lipophilic bisphosphonates as dual farnesyl\/geranylgeranyl diphosphate synthase inhibitors: An X-ray and NMR investigation","volume":"131","author":"Zhang","year":"2009","journal-title":"J. Am. Chem. Soc."},{"key":"ref_104","doi-asserted-by":"crossref","unstructured":"Zhang, Y., Cao, R., Leon, A., Guo, R.T., Krysiak, K., Yin, F., Hudock, M.P., Mukherjee, S., Gao, Y., and Robinson, H. (2007). Bisphosphonates: Teaching old drugs with new tricks, doi:10.2210\/pdb2ogd\/pdb.","DOI":"10.2210\/pdb2ogd\/pdb"},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1002\/prot.20754","article-title":"Structure and mechanism of the farnesyl diphosphate synthase from Trypanosoma cruzi: Implications for drug design","volume":"62","author":"Gabelli","year":"2006","journal-title":"Proteins"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1002\/prot.22614","article-title":"Binding of nitrogen-containing bisphosphonates (N-BPs) to the Trypanosoma cruzi farnesyl diphosphate synthase homodimer","volume":"78","author":"Huang","year":"2010","journal-title":"Proteins"},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"6445","DOI":"10.1021\/jm300425y","article-title":"Design, synthesis, calorimetry, and crystallographic analysis of 2-alkylaminoethyl-1,1-bisphosphonates as inhibitors of Trypanosoma cruzi farnesyl diphosphate synthase","volume":"55","author":"Aripirala","year":"2012","journal-title":"J. Med. Chem."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.jmb.2007.01.005","article-title":"Ferredoxin-NADP+ reductase from Plasmodium falciparum undergoes NADP+-dependent dimerization and inactivation: Functional and crystallographic analysis","volume":"367","author":"Milani","year":"2007","journal-title":"J. Mol. Biol."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"2501","DOI":"10.1038\/srep02501","article-title":"Small molecule Plasmodium FKBP35 inhibitor as a potential antimalaria agent","volume":"3","author":"Harikishore","year":"2013","journal-title":"Sci. Rep."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1006\/jmbi.2000.3910","article-title":"Structures of type 2 peroxisomal targeting signals in two trypanosomatid aldolases","volume":"300","author":"Chudzik","year":"2000","journal-title":"J. Mol. Biol."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"9533","DOI":"10.1021\/bi700615r","article-title":"Carboxy-terminus recruitment induced by substrate binding in eukaryotic fructose bis-phosphate aldolases","volume":"46","author":"Sygusch","year":"2007","journal-title":"Biochemistry"},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"4388","DOI":"10.1021\/bi972233h","article-title":"Crystal structure of fructose-1,6-bisphosphate aldolase from the human malaria parasite Plasmodium falciparum","volume":"37","author":"Kim","year":"1998","journal-title":"Biochemistry"},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.molbiopara.2012.01.007","article-title":"Biochemical and structural characterization of Plasmodium falciparum glutamate dehydrogenase 2","volume":"183","author":"Zocher","year":"2012","journal-title":"Mol. Biochem. Parasitol."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1042\/BJ20091167","article-title":"Structural insights into the catalytic mechanism of Trypanosoma cruzi GPXI (glutathione peroxidase-like enzyme I)","volume":"425","author":"Patel","year":"2010","journal-title":"Biochem. J."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/S0022-2836(03)00347-4","article-title":"Glutathione reductase of the malarial parasite Plasmodium falciparum: Crystal structure and inhibitor development","volume":"328","author":"Sarma","year":"2003","journal-title":"J. Mol. Biol."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"13821","DOI":"10.1073\/pnas.2333763100","article-title":"X-ray structure of glutathione S-transferase from the malarial parasite Plasmodium falciparum","volume":"100","author":"Becker","year":"2003","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1074\/jbc.M309663200","article-title":"Native and inhibited structure of a Mu class-related glutathione S-transferase from Plasmodium falciparum","volume":"279","author":"Perbandt","year":"2004","journal-title":"J. Biol. Chem."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1110\/ps.051891106","article-title":"Plasmodium falciparum glutathione S-transferase\u2014Structural and mechanistic studies on ligand binding and enzyme inhibition","volume":"15","author":"Hiller","year":"2006","journal-title":"Protein Sci."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"14975","DOI":"10.1021\/bi00046a004","article-title":"Crystal structure of glycosomal glyceraldehyde-3-phosphate dehydrogenase from Leishmania mexicana: Implications for structure-based drug design and a new position for the inorganic phosphate binding site","volume":"34","author":"Kim","year":"1995","journal-title":"Biochemistry"},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1006\/jmbi.1998.1661","article-title":"Crystal structure of Leishmania mexicana glycosomal glyceraldehyde-3-phosphate dehydrogenase in a new crystal form confirms the putative physiological active site structure","volume":"278","author":"Kim","year":"1998","journal-title":"J. Mol. Biol."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"4273","DOI":"10.1073\/pnas.96.8.4273","article-title":"Structure-based design of submicromolar, biologically active inhibitors of trypanosomatid glyceraldehyde-3-phosphate dehydrogenase","volume":"96","author":"Aronov","year":"1999","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1107\/S0907444905018317","article-title":"Structure of glyceraldehyde-3-phosphate dehydrogenase from Plasmodium falciparum","volume":"61","author":"Satchell","year":"2005","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1002\/prot.20801","article-title":"Crystal structure of glyceraldehyde-3-phosphate dehydrogenase from Plasmodium falciparum at 2.25 \u00c5 resolution reveals intriguing extra electron density in the active site","volume":"62","author":"Robien","year":"2006","journal-title":"Proteins"},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"2355","DOI":"10.1073\/pnas.90.6.2355","article-title":"Structure of glycosomal glyceraldehyde-3-phosphate dehydrogenase from Trypanosoma brucei determined from Laue data","volume":"90","author":"Vellieux","year":"1993","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_125","doi-asserted-by":"crossref","unstructured":"Seattle Structural Genomics Center for Infectious Disease, Abendroth, J., Lorimer, D., and Edwards, T.E. (2014). Structure of a glycosomal glyceraldehyde 3-phosphate dehydrogenase from Trypanosoma brucei, doi:10.2210\/pdb4p8r\/pdb.","DOI":"10.2210\/pdb4p8r\/pdb"},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0014-5793(02)02700-X","article-title":"Structure of Trypanosoma cruzi glycosomal glyceraldehyde-3-phosphate dehydrogenase complexed with chalepin, a natural product inhibitor, at 1.95 \u00c5 resolution","volume":"520","author":"Castilho","year":"2002","journal-title":"FEBS Lett."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"7143","DOI":"10.1021\/bi0206107","article-title":"Evidence for the two phosphate binding sites of an analogue of the thioacyl intermediate for the Trypanosoma cruzi glyceraldehyde-3-phosphate dehydrogenase-catalyzed reaction, from its crystal structure","volume":"42","author":"Castilho","year":"2003","journal-title":"Biochemistry"},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"4574","DOI":"10.1046\/j.1432-1033.2003.03857.x","article-title":"Crystal structure of Trypanosoma cruzi glyceraldehyde-3-phosphate dehydrogenase complexed with an analogue of 1,3-bisphospho-d-glyceric acid","volume":"270","author":"Ladame","year":"2003","journal-title":"Eur. J. Biochem."},{"key":"ref_129","doi-asserted-by":"crossref","unstructured":"Balliano, T.L., Guido, R.V.C., Andricopulo, A.D., and Oliva, G. (2009). Structure of glycosomal glyceraldehyde-3-phosphate dehydrogenase from Trypanosoma cruzi in complex with the irreversible iodoacetamide inhibitor, doi:10.2210\/pdb3ids\/pdb.","DOI":"10.2210\/pdb3ids\/pdb"},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/S0969-2126(00)00135-0","article-title":"A potential target enzyme for trypanocidal drugs revealed by the crystal structure of NAD-dependent glycerol-3-phosphate dehydrogenase from Leishmania mexicana","volume":"8","author":"Suresh","year":"2000","journal-title":"Structure"},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1016\/S1074-5521(02)00243-0","article-title":"Anomalous differences of light elements in determining precise binding modes of ligands to glycerol-3-phosphate dehydrogenase","volume":"9","author":"Choe","year":"2002","journal-title":"Chem. Biol."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/S0022-2836(03)00421-2","article-title":"Leishmania mexicana glycerol-3-phosphate dehydrogenase showed conformational changes upon binding a bi-substrate adduct","volume":"329","author":"Choe","year":"2003","journal-title":"J. Mol. Biol."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1111\/j.1365-2958.2006.05022.x","article-title":"Specificity of the trypanothione-dependent Leishmania major glyoxalase I: Structure and biochemical comparison with the human enzyme","volume":"59","author":"Ariza","year":"2006","journal-title":"Mol. Microbiol."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1021\/bi700989m","article-title":"Catalysis and structural properties of Leishmania infantum glyoxalase II: Trypanothione specificity and phylogeny","volume":"47","author":"Silva","year":"2008","journal-title":"Biochemistry"},{"key":"ref_135","doi-asserted-by":"crossref","unstructured":"Wernimont, A.K., Dong, A., Hills, T., Amani, M., Perieteanu, A., Lin, Y.H., Loppnau, P., Arrowsmith, C.H., Edwards, A.M., and Bountra, C. (2011). Crystal Structure of PF10_0123, a GMP synthetase from Plasmodium falciparum, doi:10.2210\/pdb3uow\/pdb.","DOI":"10.2210\/pdb3uow\/pdb"},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.molbiopara.2006.10.011","article-title":"Genome-scale protein expression and structural biology of Plasmodium falciparum and related Apicomplexan organisms","volume":"151","author":"Vedadi","year":"2007","journal-title":"Mol. Biochem. Parasitol."},{"key":"ref_137","doi-asserted-by":"crossref","unstructured":"Wernimont, A.K., Tempel, W., Lin, Y.H., Hutchinson, A., Mackenzie, F., Fairlamb, A., Kozieradzki, I., Cossar, D., Zhao, Y., and Schapira, M. (2009). Crystal structure of the amino-terminal domain of HSP90 from Leishmania major, LmjF33.0312:M1-K213, doi:10.2210\/pdb3h80\/pdb.","DOI":"10.2210\/pdb3h80\/pdb"},{"key":"ref_138","doi-asserted-by":"crossref","unstructured":"Wernimont, A.K., Tempel, W., Lin, Y.H., Hutchinson, A., MacKenzie, F., Fairlamb, A., Cossar, D., Zhao, Y., Schapira, M., and Arrowsmith, C.H. (2011). Crystal structure of the amino-terminal domain of HSP90 from Leishmania major, LMJF33.0312:M1-K213, doi:10.2210\/pdb3q5j\/pdb, doi:10.2210\/pdb3q5k\/pdb, doi:10.2210\/pdb3q5l\/pdb.","DOI":"10.2210\/pdb3q5k\/pdb"},{"key":"ref_139","doi-asserted-by":"crossref","unstructured":"Hills, T., Pizarro, J.C., Wernimont, A.K., Ferguson, M.A.J., and Hui, R. (2012). Crystal structure of the N-terminal domain of Hsp90 from Leishmania major (LmjF33.0312) in complex with ADP, doi:10.2210\/pdb3u67\/pdb.","DOI":"10.2210\/pdb3u67\/pdb"},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.jmb.2010.01.051","article-title":"Crystal structures of trypanosomal histidyl-tRNA synthetase illuminate differences between eukaryotic and prokaryotic homologs","volume":"397","author":"Merritt","year":"2010","journal-title":"J. Mol. Biol."},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.jmb.2009.03.011","article-title":"Crystal structures of the histo-aspartic protease (HAP) from Plasmodium falciparum","volume":"388","author":"Bhaumik","year":"2009","journal-title":"J. Mol. Biol."},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.jsb.2011.07.018","article-title":"Structural basis for the functional and inhibitory mechanisms of \u03b2-hydroxyacyl-acyl carrier protein dehydratase (FabZ) of Plasmodium falciparum","volume":"176","author":"Maity","year":"2011","journal-title":"J. Struct. Biol."},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"3968","DOI":"10.1016\/j.febslet.2013.10.029","article-title":"Structure of the (E)-4-hydroxy-3-methyl-but-2-enyl-diphosphate reductase from Plasmodium falciparum","volume":"587","author":"Rekittke","year":"2013","journal-title":"FEBS Lett."},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"9872","DOI":"10.1021\/bi990664p","article-title":"The 2.0 \u00c5 structure of malarial purine phosphoribosyltransferase in complex with a transition-state analogue inhibitor","volume":"38","author":"Shi","year":"1999","journal-title":"Biochemistry"},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"17120","DOI":"10.1021\/bi9821465","article-title":"Approaching the transition state in the crystal structure of a phosphoribosyltransferase","volume":"37","author":"Focia","year":"1998","journal-title":"Biochemistry"},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/j.jmb.2003.11.012","article-title":"Interactions at the dimer interface influence the relative efficiencies for purine nucleotide synthesis and pyrophosphorolysis in a phosphoribosyltransferase","volume":"335","author":"Canyuk","year":"2004","journal-title":"J. Mol. Biol."},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1038\/nsb1196-912","article-title":"The structure of lactate dehydrogenase from Plasmodium falciparum reveals a new target for anti-malarial design","volume":"3","author":"Dunn","year":"1996","journal-title":"Nat. Struct. Biol."},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"10213","DOI":"10.1074\/jbc.274.15.10213","article-title":"Chloroquine binds in the cofactor binding site of Plasmodium falciparum lactate dehydrogenase","volume":"274","author":"Read","year":"1999","journal-title":"J. Biol. Chem."},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"31429","DOI":"10.1074\/jbc.M402433200","article-title":"Identification and activity of a series of azole-based compounds with lactate dehydrogenase-directed anti-malarial activity","volume":"279","author":"Cameron","year":"2004","journal-title":"J. Biol. Chem."},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.molbiopara.2005.03.015","article-title":"Mapping the binding site for gossypol-like inhibitors of Plasmodium falciparum lactate dehydrogenase","volume":"142","author":"Conners","year":"2005","journal-title":"Mol. Biochem. Parasitol."},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"16221","DOI":"10.1021\/bi051416y","article-title":"Structure of lactate dehydrogenase from Plasmodium vivax: Complexes with NADH and APADH","volume":"44","author":"Chaikuad","year":"2005","journal-title":"Biochemistry"},{"key":"ref_152","doi-asserted-by":"crossref","unstructured":"Birkinshaw, R.W., and Brady, R.L. (2012). The crystal structure of Plasmodium falciparum L-lactate dehydrogenase in complex with a novel bicine ligand, doi:10.2210\/pdb4b7u\/pdb.","DOI":"10.2210\/pdb4b7u\/pdb"},{"key":"ref_153","doi-asserted-by":"crossref","unstructured":"Werner, C., Krauth-Siegel, R.L., Stubbs, M.T., and Klebe, G. (2008). Crystal structure of lipoamide dehydrogenase from Trypanosoma cruzi: A putative target for the design of new drugs against Chagas disease, doi:10.2210\/pdb2qae\/pdb.","DOI":"10.2210\/pdb2qae\/pdb"},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1107\/S0907444913001923","article-title":"Structural analysis of malaria-parasite lysyl-tRNA synthetase provides a platform for drug development","volume":"69","author":"Khan","year":"2013","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"5213","DOI":"10.1021\/jm4005972","article-title":"Synthesis and structure-activity relationships of phosphonic arginine mimetics as inhibitors of the M1 and M17 aminopeptidases from Plasmodium falciparum","volume":"56","author":"Paiardini","year":"2013","journal-title":"J. Med. Chem."},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"2449","DOI":"10.1073\/pnas.0911813107","article-title":"Structure of the Plasmodium falciparum M17 aminopeptidase and significance for the design of drugs targeting the neutral exopeptidases","volume":"107","author":"McGowan","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"E526","DOI":"10.1073\/pnas.1105601108","article-title":"Bestatin-based chemical biology strategy reveals distinct roles for malaria M1- and M17-family aminopeptidases","volume":"108","author":"Harbut","year":"2011","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.jmb.2012.06.006","article-title":"X-ray crystal structure and specificity of the Plasmodium falciparum malaria aminopeptidase PfM18AAP","volume":"422","author":"Sivaraman","year":"2012","journal-title":"J. Mol. Biol."},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1093\/embo-reports\/kvf009","article-title":"Trypanosoma cruzi macrophage infectivity potentiator has a rotamase core and a highly exposed alpha-helix","volume":"3","author":"Pereira","year":"2002","journal-title":"EMBO Rep."},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"7469","DOI":"10.1073\/pnas.1200885109","article-title":"Crystal structure of a Trypanosoma brucei metacaspase","volume":"109","author":"McLuskey","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1111\/j.1365-2958.2008.06444.x","article-title":"The molecular analysis of Trypanosoma cruzi metallocarboxypeptidase 1 provides insight into fold and substrate specificity","volume":"70","author":"Niemirowicz","year":"2008","journal-title":"Mol. Microbiol."},{"key":"ref_162","doi-asserted-by":"crossref","unstructured":"Wernimont, A.K., Artz, J.D., Crombet, L., Lew, J., Weadge, J., Arrowsmith, C.H., Edwards, A.M., Weigelt, J., Bountra, C., and Hui, R. (2011). Crystal structure of methionine aminopeptidase 1b from Plasmodium falciparum, PF10_0150, doi:10.2210\/pdb3s6b\/pdb.","DOI":"10.2210\/pdb3s6b\/pdb"},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/j.biochi.2010.11.015","article-title":"Structure of Leishmania major methionyl-tRNA synthetase in complex with intermediate products methionyladenylate and pyrophosphate","volume":"93","author":"Larson","year":"2011","journal-title":"Biochimie"},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1016\/j.str.2012.07.011","article-title":"Distinct states of methionyl-tRNA synthetase indicate inhibitor binding by conformational selection","volume":"20","author":"Koh","year":"2012","journal-title":"Structure"},{"key":"ref_165","doi-asserted-by":"crossref","unstructured":"Koh, C.Y., Kim, J.E., Wetzel, A.B., de van der Schueren, W.J., Shibata, S., Ranade, R.M., Liu, J., Zhang, Z., Gillespie, J.R., and Buckner, F.S. (2014). Structures of Trypanosoma brucei methionyl-tRNA synthetase with urea-based inhibitors provide guidance for drug design against sleeping sickness. PLoS Negl. Trop. Dis., 8.","DOI":"10.1371\/journal.pntd.0002775"},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1016\/j.str.2012.07.005","article-title":"The crystal structure of the MAP kinase LmaMPK10 from Leishmania major reveals parasite-specific features and regulatory mechanisms","volume":"20","author":"Horjales","year":"2012","journal-title":"Structure"},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.molbiopara.2011.11.004","article-title":"The crystal structure of Leishmania major N5,N10-methylenetetrahydrofolate dehydrogenase\/cyclohydrolase and assessment of a potential drug target","volume":"181","author":"Eadsforth","year":"2012","journal-title":"Mol. Biochem. Parasitol."},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/j.1365-2958.2011.07799.x","article-title":"The Leishmania nicotinamidase is essential for NAD+ production and parasite proliferation","volume":"82","author":"Gazanion","year":"2011","journal-title":"Mol. Microbiol."},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/j.jmb.2009.12.032","article-title":"N-myristoyltransferase from Leishmania donovani: Structural and functional characterisation of a potential drug target for visceral leishmaniasis","volume":"396","author":"Brannigan","year":"2010","journal-title":"J. Mol. Biol."},{"key":"ref_170","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1038\/nature08893","article-title":"N-myristoyltransferase inhibitors as new leads to treat sleeping sickness","volume":"464","author":"Frearson","year":"2010","journal-title":"Nature"},{"key":"ref_171","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1021\/jm201091t","article-title":"Discovery of a novel class of orally active trypanocidal N-myristoyltransferase inhibitors","volume":"55","author":"Brand","year":"2012","journal-title":"J. Med. Chem."},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"5939","DOI":"10.1021\/jm060429m","article-title":"Using fragment cocktail crystallography to assist inhibitor design of Trypanosoma brucei nucleoside 2-deoxyribosyltransferase","volume":"49","author":"Bosch","year":"2006","journal-title":"J. Med. Chem."},{"key":"ref_173","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.1039\/c0mb00307g","article-title":"Molecular adaptability of nucleoside diphosphate kinase b from trypanosomatid parasites: Stability, oligomerization and structural determinants of nucleotide binding","volume":"7","author":"Souza","year":"2011","journal-title":"Mol. Biosyst."},{"key":"ref_174","doi-asserted-by":"crossref","unstructured":"Gardberg, A.S., Edwards, T.E., and Seattle Structural Genomics Center for Infectious Disease (2012). Crystal structure of nucleoside diphosphate kinase B from Trypanosoma brucei, doi:10.2210\/pdb4fkx\/pdb, doi:10.2210\/pdb4fky\/pdb.","DOI":"10.2210\/pdb4fkx\/pdb"},{"key":"ref_175","doi-asserted-by":"crossref","unstructured":"Seattle Structural Genomics Center for Infectious Disease, Gardberg, A.S., Edwards, T.E., Staker, B., and Stewart, L. (2012). Crystal structure of nucleoside diphosphate kinase B from Trypanosoma brucei, doi:10.2210\/pdb4f4a\/pdb, doi:10.2210\/pdb4f36\/pdb.","DOI":"10.2210\/pdb4f4a\/pdb"},{"key":"ref_176","doi-asserted-by":"crossref","first-page":"21114","DOI":"10.1074\/jbc.274.30.21114","article-title":"Nucleoside hydrolase from Leishmania major. Cloning, expression, catalytic properties, transition state inhibitors, and the 2.5-\u01fa crystal structure","volume":"274","author":"Shi","year":"1999","journal-title":"J. Biol. Chem."},{"key":"ref_177","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1107\/S0907444913010792","article-title":"Structures of purine nucleosidase from Trypanosoma brucei bound to isozyme-specific trypanocidals and a novel metalorganic inhibitor","volume":"69","author":"Giannese","year":"2013","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"ref_178","doi-asserted-by":"crossref","first-page":"8999","DOI":"10.1021\/bi100697d","article-title":"Structure and mechanism of the 6-oxopurine nucleosidase from Trypanosoma brucei brucei","volume":"49","author":"Vandemeulebrouke","year":"2010","journal-title":"Biochemistry"},{"key":"ref_179","doi-asserted-by":"crossref","first-page":"10076","DOI":"10.1074\/jbc.M808633200","article-title":"Crystal structure of malaria parasite nucleosome assembly protein: Distinct modes of protein localization and histone recognition","volume":"284","author":"Gill","year":"2009","journal-title":"J. Biol. Chem."},{"key":"ref_180","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1107\/S0907444909013171","article-title":"Iodide-SAD, SIR and SIRAS phasing for structure solution of a nucleosome assembly protein","volume":"65","author":"Yogavel","year":"2009","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"ref_181","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1093\/jb\/mvr096","article-title":"Structural insight into the stereoselective production of PGF2\u03b1 by Old Yellow Enzyme from Trypanosoma cruzi","volume":"150","author":"Okamoto","year":"2011","journal-title":"J. Biochem."},{"key":"ref_182","doi-asserted-by":"crossref","unstructured":"Murakami, M.T., Rodrigues, N.C., Gava, L.M., Canduri, F., Oliva, G., Barbosa, L.R.S., and Borgers, J.C. (2013). High resolution crystal structure and in solution studies of the old yellow enzyme from Trypanosoma cruzi: Insights into oligomerization, enzyme dynamics and specificity, doi:10.2210\/pdb4e2b\/pdb, doi:10.2210\/pdb4e2d\/pdb.","DOI":"10.2210\/pdb4e2b\/pdb"},{"key":"ref_183","doi-asserted-by":"crossref","first-page":"39249","DOI":"10.1074\/jbc.M110.156679","article-title":"Crystal structure of Leishmania major oligopeptidase B gives insight into the enzymatic properties of a trypanosomatid virulence factor","volume":"285","author":"McLuskey","year":"2010","journal-title":"J. Biol. Chem."},{"key":"ref_184","doi-asserted-by":"crossref","unstructured":"Canning, P., Rea, D., Morty, R.E., and F\u00fcl\u00f6p, V. (2013). Crystal structures of Trypanosoma brucei oligopeptidase B broaden the paradigm of catalytic regulation in prolyl oligopeptidase family enzymes. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0079349"},{"key":"ref_185","doi-asserted-by":"crossref","first-page":"15174","DOI":"10.1021\/bi9915115","article-title":"X-ray structure of ornithine decarboxylase from Trypanosoma brucei: The native structure and the structure in complex with alpha-difluoromethylornithine","volume":"38","author":"Grishin","year":"1999","journal-title":"Biochemistry"},{"key":"ref_186","doi-asserted-by":"crossref","first-page":"11247","DOI":"10.1021\/bi001209s","article-title":"Altering the reaction specificity of eukaryotic ornithine decarboxylase","volume":"39","author":"Jackson","year":"2000","journal-title":"Biochemistry"},{"key":"ref_187","doi-asserted-by":"crossref","first-page":"22037","DOI":"10.1074\/jbc.M300188200","article-title":"X-ray structure determination of Trypanosoma brucei ornithine decarboxylase bound to d-ornithine and to G418: Insights into substrate binding and ODC conformational flexibility","volume":"278","author":"Jackson","year":"2003","journal-title":"J. Biol. Chem."},{"key":"ref_188","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.jmb.2010.07.039","article-title":"Redox regulation of Plasmodium falciparum ornithine \u03b4-aminotransferase","volume":"402","author":"Jortzik","year":"2010","journal-title":"J. Mol. Biol."},{"key":"ref_189","doi-asserted-by":"crossref","first-page":"20930","DOI":"10.1074\/jbc.M111.228213","article-title":"The Leishmania donovani UMP synthase is essential for promastigote viability and has an unusual tetrameric structure that exhibits substrate-controlled oligomerization","volume":"286","author":"French","year":"2011","journal-title":"J. Biol. Chem."},{"key":"ref_190","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1021\/jm7010673","article-title":"Structure-activity relationships of C6-uridine derivatives targeting plasmodia orotidine monophosphate decarboxylase","volume":"51","author":"Bello","year":"2008","journal-title":"J. Med. Chem."},{"key":"ref_191","doi-asserted-by":"crossref","first-page":"3842","DOI":"10.1021\/bi702390k","article-title":"Structure and inhibition of orotidine 5\u2032-monophosphate decarboxylase from Plasmodium falciparum","volume":"47","author":"Langley","year":"2008","journal-title":"Biochemistry"},{"key":"ref_192","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1093\/jb\/mvm193","article-title":"Structural basis for the decarboxylation of orotidine 5\u2032-monophosphate (OMP) by Plasmodium falciparum OMP decarboxylase","volume":"143","author":"Tokuoka","year":"2008","journal-title":"J. Biochem."},{"key":"ref_193","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1021\/jm801224t","article-title":"Structure-activity relationships of orotidine-5\u2032-monophosphate decarboxylase inhibitors as anticancer agents","volume":"52","author":"Bello","year":"2009","journal-title":"J. Med. Chem."},{"key":"ref_194","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1093\/jb\/mvs070","article-title":"The in silico screening and X-ray structure analysis of the inhibitor complex of Plasmodium falciparum orotidine 5\u2032-monophosphate decarboxylase","volume":"152","author":"Takashima","year":"2012","journal-title":"J. Biochem."},{"key":"ref_195","doi-asserted-by":"crossref","unstructured":"Liu, Y., Lau, W., Lew, J., Amani, M., Hui, R., and Pai, E.F. (2005). Crystal structure of orotidine 5\u2032-phosphate decarboxylase from Plasmodium falciparum, doi:10.2210\/pdb2f84\/pdb.","DOI":"10.2210\/pdb2f84\/pdb"},{"key":"ref_196","doi-asserted-by":"crossref","unstructured":"Caruthers, J.M., Robein, M., Zucker, F., Mehlin, C., Luft, J., Boni, E., Lauricella, A., Merritt, E.A., and Hol, W.G.J. (2005). Crystal structure of an orotidine-5\u2032-monophosphate decarboxylase homolog from P. falciparum, doi:10.2210\/pdb2f84\/pdb.","DOI":"10.2210\/pdb2f84\/pdb"},{"key":"ref_197","doi-asserted-by":"crossref","unstructured":"Liu, Y., Kotra, L.P., and Pai, E.F. (2011). Crystal structure of Plasmodium falciparum orotidine 5\u2032-monophosphate decarboxylase, doi:10.2210\/pdb3mwa\/pdb, doi:10.2210\/pdb3n2m\/pdb, doi:10.2210\/pdb3n34\/pdb, doi:10.2210\/pdb3n3m\/pdb.","DOI":"10.2210\/pdb3n2m\/pdb"},{"key":"ref_198","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1042\/BJ20050832","article-title":"Kinetic, inhibition and structural studies on 3-oxoacyl-ACP reductase from Plasmodium falciparum, a key enzyme in fatty acid biosynthesis","volume":"393","author":"Wickramasinghe","year":"2006","journal-title":"Biochem. J."},{"key":"ref_199","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/S0969-2126(02)00719-0","article-title":"Crystals of peptide deformylase from Plasmodium falciparum reveal critical characteristics of the active site for drug design","volume":"10","author":"Kumar","year":"2002","journal-title":"Structure"},{"key":"ref_200","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1110\/ps.03456404","article-title":"An improved crystal form of Plasmodium falciparum peptide deformylase","volume":"13","author":"Robien","year":"2004","journal-title":"Protein Sci."},{"key":"ref_201","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/j.jmb.2008.05.089","article-title":"Structural insights into the recognition of peroxisomal targeting signal 1 by Trypanosoma brucei peroxin 5","volume":"381","author":"Sampathkumar","year":"2008","journal-title":"J. Mol. Biol."},{"key":"ref_202","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1074\/jbc.M111.315267","article-title":"Structure and reaction mechanism of phosphoethanolamine methyltransferase from the malaria parasite Plasmodium falciparum: An antiparasitic drug target","volume":"287","author":"Lee","year":"2012","journal-title":"J. Biol. Chem."},{"key":"ref_203","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1111\/j.1365-2958.2007.05976.x","article-title":"Crystal structure of the Leishmania major phosphodiesterase LmjPDEB1 and insight into the design of the parasite-selective inhibitors","volume":"66","author":"Wang","year":"2007","journal-title":"Mol. Microbiol."},{"key":"ref_204","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1021\/jm3017877","article-title":"Discovery of novel Trypanosoma brucei phosphodiesterase B1 inhibitors by virtual screening against the unliganded TbrPDEB1 crystal structure","volume":"56","author":"Jansen","year":"2013","journal-title":"J. Med. Chem."},{"key":"ref_205","doi-asserted-by":"crossref","first-page":"11788","DOI":"10.1074\/jbc.M111.326777","article-title":"Biological and structural characterization of Trypanosoma cruzi phosphodiesterase C and implications for design of parasite selective inhibitors","volume":"287","author":"Wang","year":"2012","journal-title":"J. Biol. Chem."},{"key":"ref_206","doi-asserted-by":"crossref","unstructured":"Wang, H., Kunz, S., Chen, G., Seebeck, T., Wan, Y., Robinson, H., Martinelli, S., and Ke, H. (2012). TcrPDEC1 catalytic domain in complex with inhibitor wyq16, doi:10.2210\/pdb3v94\/pdb.","DOI":"10.2210\/pdb3v94\/pdb"},{"key":"ref_207","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1006\/jmbi.2001.5093","article-title":"Crystal structure of the dimeric phosphoenolpyruvate carboxykinase (PEPCK) from Trypanosoma cruzi at 2 \u00c5 resolution","volume":"313","author":"Trapani","year":"2001","journal-title":"J. Mol. Biol."},{"key":"ref_208","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1016\/j.jmb.2008.11.047","article-title":"The crystal structure of ATP-bound phosphofructokinase from Trypanosoma brucei reveals conformational transitions different from those of other phosphofructokinases","volume":"385","author":"McNae","year":"2009","journal-title":"J. Mol. Biol."},{"key":"ref_209","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1016\/j.jmb.2006.11.063","article-title":"Three dimensional structure and implications for the catalytic mechanism of 6-phosphogluconolactonase from Trypanosoma brucei","volume":"366","author":"Delarue","year":"2007","journal-title":"J. Mol. Biol."},{"key":"ref_210","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1016\/j.jmb.2009.03.063","article-title":"Insights into the enzymatic mechanism of 6-phosphogluconolactonase from Trypanosoma brucei using structural data and molecular dynamics simulation","volume":"388","author":"Poggi","year":"2009","journal-title":"J. Mol. Biol."},{"key":"ref_211","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1006\/jmbi.1998.2059","article-title":"A 2.8 \u00c5 resolution structure of 6-phosphogluconate dehydrogenase from the protozoan parasite Trypanosoma brucei: Comparison with the sheep enzyme accounts for differences in activity with coenzyme and substrate analogues","volume":"282","author":"Phillips","year":"1998","journal-title":"J. Mol. Biol."},{"key":"ref_212","doi-asserted-by":"crossref","first-page":"2765","DOI":"10.1111\/j.1432-1033.2004.04205.x","article-title":"The crystal structure of glucose-6-phosphate isomerase from Leishmania mexicana reveals novel active site features","volume":"271","author":"Cordeiro","year":"2004","journal-title":"Eur. J. Biochem."},{"key":"ref_213","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1002\/prot.22133","article-title":"Crystal structure of phosphoglucose isomerase from Trypanosoma brucei complexed with glucose-6-phosphate at 1.6 \u00c5 resolution","volume":"74","author":"Arsenieva","year":"2009","journal-title":"Proteins"},{"key":"ref_214","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.bbrc.2011.07.045","article-title":"Crystal structure of Plasmodium falciparum phosphoglycerate kinase: Evidence for anion binding in the basic patch","volume":"412","author":"Smith","year":"2011","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_215","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1038\/385275a0","article-title":"Synergistic effects of substrate-induced conformational changes in phosphoglycerate kinase activation","volume":"385","author":"Bernstein","year":"1997","journal-title":"Nature"},{"key":"ref_216","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1006\/jmbi.1998.1835","article-title":"A bisubstrate analog induces unexpected conformational changes in phosphoglycerate kinase from Trypanosoma brucei","volume":"279","author":"Bernstein","year":"1998","journal-title":"J. Mol. Biol."},{"key":"ref_217","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.jmb.2009.09.041","article-title":"Crystal structures of Leishmania mexicana phosphoglycerate mutase suggest a one-metal mechanism and a new enzyme subclass","volume":"394","author":"Nowicki","year":"2009","journal-title":"J. Mol. Biol."},{"key":"ref_218","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.molbiopara.2011.06.001","article-title":"Characterization of a new phosphatase from Plasmodium","volume":"179","author":"Hills","year":"2011","journal-title":"Mol. Biochem. Parasitol."},{"key":"ref_219","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.1111\/j.1742-4658.2012.08586.x","article-title":"Structural role of the active-site metal in the conformation of Trypanosoma brucei phosphoglycerate mutase","volume":"279","author":"Mercaldi","year":"2012","journal-title":"FEBS J."},{"key":"ref_220","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.jmb.2006.08.023","article-title":"Structure of Leishmania mexicana phosphomannomutase highlights similarities with human isoforms","volume":"363","author":"Kedzierski","year":"2006","journal-title":"J. Mol. Biol."},{"key":"ref_221","doi-asserted-by":"crossref","unstructured":"Wernimont, A.K., Lam, A., Ali, A., Lin, Y.H., Guther, L., Shamshad, A., Bandini, G., MacKenzie, F., Kozieradzki, I., and Cossar, D. (2009). Crystal structure of Trypanosoma brucei phosphomannosemutase, TB.10.700.370, doi:10.2210\/pdb3f9r\/pdb.","DOI":"10.2210\/pdb3f9r\/pdb"},{"key":"ref_222","doi-asserted-by":"crossref","first-page":"4086","DOI":"10.1021\/bi802059r","article-title":"Recombinant plasmepsin 1 from the human malaria parasite Plasmodium falciparum: Enzymatic characterization, active site inhibitor design, and structural analysis","volume":"48","author":"Liu","year":"2009","journal-title":"Biochemistry"},{"key":"ref_223","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.jsb.2011.04.009","article-title":"Crystal structures of the free and inhibited forms of plasmepsin I (PMI) from Plasmodium falciparum","volume":"175","author":"Bhaumik","year":"2011","journal-title":"J. Struct. Biol."},{"key":"ref_224","doi-asserted-by":"crossref","first-page":"10034","DOI":"10.1073\/pnas.93.19.10034","article-title":"Structure and inhibition of plasmepsin II, a hemoglobin-degrading enzyme from Plasmodium falciparum","volume":"93","author":"Silva","year":"1996","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_225","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1107\/S0907444902014695","article-title":"Structures of Ser205 mutant plasmepsin II from Plasmodium falciparum at 1.8 \u00c5 in complex with the inhibitors rs367 and rs370","volume":"58","author":"Asojo","year":"2002","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"ref_226","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0022-2836(03)00036-6","article-title":"Novel uncomplexed and complexed structures of plasmepsin II, an aspartic protease from Plasmodium falciparum","volume":"327","author":"Asojo","year":"2003","journal-title":"J. Mol. Biol."},{"key":"ref_227","doi-asserted-by":"crossref","first-page":"23837","DOI":"10.1074\/jbc.M501519200","article-title":"X-ray structure of plasmepsin II complexed with a potent achiral inhibitor","volume":"280","author":"Prade","year":"2005","journal-title":"J. Biol. Chem."},{"key":"ref_228","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1002\/cmdc.200600223","article-title":"Achiral, cheap, and potent inhibitors of Plasmepsins I, II, and IV","volume":"1","author":"Boss","year":"2006","journal-title":"ChemMedChem"},{"key":"ref_229","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1107\/S0907444908041632","article-title":"Crystallographic evidence for noncoplanar catalytic aspartic acids in plasmepsin II resides in the Protein Data Bank","volume":"65","author":"Robbins","year":"2009","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"ref_230","doi-asserted-by":"crossref","unstructured":"Asojo, O.A., Silva, A.M., and Gulnik, S. (2005). Novel uncomplexed and complex structures of PM II, an aspartic protease from P. falciparum, doi:10.2210\/pdb1m43\/pdb.","DOI":"10.2210\/pdb1m43\/pdb"},{"key":"ref_231","doi-asserted-by":"crossref","unstructured":"Freire, E., Nezami, A.G., and Amzel, L.M. (2004). Crystal structure of plasmepsin II, an aspartyl protease from Plasmodium falciparum, in complex with a statine-based inhibitor, doi:10.2210\/pdb1me6\/pdb.","DOI":"10.2210\/pdb1me6\/pdb"},{"key":"ref_232","doi-asserted-by":"crossref","unstructured":"Lindberg, J., Johansson, P.-O., Rosenquist, A., Kvarnstroem, I., Vrang, L., Samuelsson, B., and Unge, T. (2006). Structural study of a novel inhibitor with bulky P1 side chain in complex with Plasmepsin II\u2014Implications for drug design, doi:10.2210\/pdb1w6h\/pdb, doi:10.2210\/pdb1w6i\/pdb.","DOI":"10.2210\/pdb1w6h\/pdb"},{"key":"ref_233","doi-asserted-by":"crossref","unstructured":"Prade, L. (2005). Structure of plasmepsin II, doi:10.2210\/pdb1xdh\/pdb, doi:10.2210\/pdb1xe5\/pdb, doi:10.2210\/pdb1xe6\/pdb.","DOI":"10.1002\/cphc.200590025"},{"key":"ref_234","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1073\/pnas.0509010103","article-title":"Crystal structure, catalytic mechanism, and mitogenic properties of Trypanosoma cruzi proline racemase","volume":"103","author":"Buschiazzo","year":"2006","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_235","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1016\/j.str.2003.09.020","article-title":"Structures of P. falciparum PfPK5 test the CDK regulation paradigm and suggest mechanisms of small molecule inhibition","volume":"11","author":"Holton","year":"2003","journal-title":"Structure"},{"key":"ref_236","doi-asserted-by":"crossref","first-page":"22075","DOI":"10.1074\/jbc.M110.108860","article-title":"The Trypanosoma brucei life cycle switch TbPTP1 is structurally conserved and dephosphorylates the nucleolar protein NOPP44\/46","volume":"285","author":"Chou","year":"2010","journal-title":"J. Biol. Chem."},{"key":"ref_237","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.molbiopara.2012.10.006","article-title":"Structure of the Trypanosoma cruzi protein tyrosine phosphatase TcPTP1, a potential therapeutic target for Chagas\u2019 disease","volume":"187","author":"Lountos","year":"2013","journal-title":"Mol. Biochem. Parasitol."},{"key":"ref_238","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1107\/S174430911004724X","article-title":"Structure of recombinant Leishmania donovani pteridine reductase reveals a disordered active site","volume":"67","author":"Barrack","year":"2011","journal-title":"Acta Crystallogr. Sect. F Struct. Biol. Cryst. Commun."},{"key":"ref_239","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1038\/88584","article-title":"Pteridine reductase mechanism correlates pterin metabolism with drug resistance in trypanosomatid parasites","volume":"8","author":"Gourley","year":"2001","journal-title":"Nat. Struct. Biol."},{"key":"ref_240","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.1107\/S0907444904018955","article-title":"Inhibition of Leishmania major pteridine reductase by 2,4,6-triaminoquinazoline: Structure of the NADPH ternary complex","volume":"60","author":"McLuskey","year":"2004","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"ref_241","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.jmb.2005.06.076","article-title":"Structures of Leishmania major pteridine reductase complexes reveal the active site features important for ligand binding and to guide inhibitor design","volume":"352","author":"Hardy","year":"2005","journal-title":"J. Mol. Biol."},{"key":"ref_242","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1073\/pnas.0704384105","article-title":"Discovery of potent pteridine reductase inhibitors to guide antiparasite drug development","volume":"105","author":"Cavazzuti","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_243","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1111\/j.1365-2958.2006.05332.x","article-title":"Structure and reactivity of Trypanosoma brucei pteridine reductase: Inhibition by the archetypal antifolate methotrexate","volume":"61","author":"Dawson","year":"2006","journal-title":"Mol. Microbiol."},{"key":"ref_244","doi-asserted-by":"crossref","first-page":"4454","DOI":"10.1021\/jm900414x","article-title":"One scaffold, three binding modes: Novel and selective pteridine reductase 1 inhibitors derived from fragment hits discovered by virtual screening","volume":"52","author":"Mpamhanga","year":"2009","journal-title":"J. Med. Chem."},{"key":"ref_245","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.ab.2009.09.003","article-title":"Development and validation of a cytochrome c-coupled assay for pteridine reductase 1 and dihydrofolate reductase","volume":"396","author":"Shanks","year":"2010","journal-title":"Anal. Biochem."},{"key":"ref_246","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1021\/jm901059x","article-title":"Structure-based design of pteridine reductase inhibitors targeting African sleeping sickness and the leishmaniases","volume":"53","author":"Tulloch","year":"2010","journal-title":"J. Med. Chem."},{"key":"ref_247","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1107\/S0907444910040886","article-title":"High-resolution structures of Trypanosoma brucei pteridine reductase ligand complexes inform on the placement of new molecular entities in the active site of a potential drug target","volume":"66","author":"Dawson","year":"2010","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"ref_248","doi-asserted-by":"crossref","unstructured":"Nerini, E., Dawson, A., Hannaert, V., Michels, P.A., Hunter, W.N., and Costi, M.P. (2012). Structural studies of thiadiazole derivatives that inhibit Trypanosoma brucei growth, doi:10.2210\/pdb2yhi\/pdb.","DOI":"10.2210\/pdb2yhi\/pdb"},{"key":"ref_249","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.jsb.2005.07.008","article-title":"Crystal structure of Trypanosoma cruzi pteridine reductase 2 in complex with a substrate and an inhibitor","volume":"152","author":"Schormann","year":"2005","journal-title":"J. Struct. Biol."},{"key":"ref_250","doi-asserted-by":"crossref","first-page":"18103","DOI":"10.1074\/jbc.C400068200","article-title":"Plasmodium falciparum purine nucleoside phosphorylase: Crystal structures, immucillin inhibitors, and dual catalytic function","volume":"279","author":"Shi","year":"2004","journal-title":"J. Biol. Chem."},{"key":"ref_251","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1107\/S0907444905020251","article-title":"Structures of Plasmodium falciparum purine nucleoside phosphorylase complexed with sulfate and its natural substrate inosine","volume":"61","author":"Schnick","year":"2005","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"ref_252","doi-asserted-by":"crossref","unstructured":"Chaikuad, A., and Brady, R.L. (2009). Conservation of structure and activity in Plasmodium purine nucleoside phosphorylases. BMC Struct. Biol., 9.","DOI":"10.1186\/1472-6807-9-42"},{"key":"ref_253","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1111\/j.1365-2958.2012.08189.x","article-title":"Chemical, genetic and structural assessment of pyridoxal kinase as a drug target in the African trypanosome","volume":"86","author":"Jones","year":"2012","journal-title":"Mol. Microbiol."},{"key":"ref_254","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1006\/jmbi.1999.2918","article-title":"The structure of pyruvate kinase from Leishmania mexicana reveals details of the allosteric transition and unusual effector specificity","volume":"291","author":"Rigden","year":"1999","journal-title":"J. Mol. Biol."},{"key":"ref_255","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/j.jmb.2008.08.037","article-title":"Sulphate removal induces a major conformational change in Leishmania mexicana pyruvate kinase in the crystalline state","volume":"383","author":"Tulloch","year":"2008","journal-title":"J. Mol. Biol."},{"key":"ref_256","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1107\/S1744309109053494","article-title":"An improved strategy for the crystallization of Leishmania mexicana pyruvate kinase","volume":"66","author":"Morgan","year":"2010","journal-title":"Acta Crystallogr. Sect. F Struct. Biol. Cryst. Commun."},{"key":"ref_257","doi-asserted-by":"crossref","first-page":"12892","DOI":"10.1074\/jbc.M109.079905","article-title":"Allosteric mechanism of pyruvate kinase from Leishmania mexicana uses a rock and lock model","volume":"285","author":"Morgan","year":"2010","journal-title":"J. Biol. Chem."},{"key":"ref_258","doi-asserted-by":"crossref","first-page":"31232","DOI":"10.1074\/jbc.M110.212613","article-title":"The trypanocidal drug suramin and other trypan blue mimetics are inhibitors of pyruvate kinases and bind to the adenosine site","volume":"286","author":"Morgan","year":"2011","journal-title":"J. Biol. Chem."},{"key":"ref_259","doi-asserted-by":"crossref","unstructured":"Morgan, H.P., Walsh, M., Blackburn, E.A., Wear, M.A., Boxer, M., Shen, M., McNae, I.W., Michels, P.A.M., Auld, D.S., and Fothergill-Gilmore, L.A. (2012). A new class of suicide inhibitor blocks nucleotide binding to pyruvate kinase, doi:10.2210\/pdb3srk\/pdb.","DOI":"10.2210\/pdb3srk\/pdb"},{"key":"ref_260","doi-asserted-by":"crossref","unstructured":"Wernimont, A.K., Hutchinson, A., Hassanali, A., Mackenzie, F., Cossar, D., Bochkarev, A., Arrowsmith, C.H., Bountra, C., Weigelt, J., and Edwards, A.M. (2005). Crystal structure of PFF1300w, doi:10.2210\/pdb3khd\/pdb.","DOI":"10.2210\/pdb3khd\/pdb"},{"key":"ref_261","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1107\/S0907444913013875","article-title":"\u2018In crystallo\u2019 substrate binding triggers major domain movements and reveals magnesium as a co-activator of Trypanosoma brucei pyruvate kinase","volume":"69","author":"Zhong","year":"2013","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"ref_262","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1042\/BJ20130790","article-title":"Pyruvate kinases have an intrinsic and conserved decarboxylase activity","volume":"458","author":"Zhong","year":"2014","journal-title":"Biochem. J."},{"key":"ref_263","doi-asserted-by":"crossref","unstructured":"Marion, R., Hansell, E., Caffrey, C., Roush, W.R., and Brinen, L.S. (2008). The high resolution structure of rhodesain, the major cathepsin L protease from Trypanosoma brucei rhodesiense, illustrates the basis for differences in inhibition profiles from other papain family cysteine proteases, doi:10.2210\/pdb2p86\/pdb.","DOI":"10.2210\/pdb2p86\/pdb"},{"key":"ref_264","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1111\/j.1742-4658.2010.07999.x","article-title":"Structures of type B ribose 5-phosphate isomerase from Trypanosoma cruzi shed light on the determinants of sugar specificity in the structural family","volume":"278","author":"Stern","year":"2011","journal-title":"FEBS J."},{"key":"ref_265","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1002\/prot.20764","article-title":"Structure of a ribulose 5-phosphate 3-epimerase from Plasmodium falciparum","volume":"62","author":"Caruthers","year":"2006","journal-title":"Proteins"},{"key":"ref_266","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.jmb.2004.08.041","article-title":"High resolution crystal structure of a key editosome enzyme from Trypanosoma brucei: RNA editing ligase 1","volume":"343","author":"Deng","year":"2004","journal-title":"J. Mol. Biol."},{"key":"ref_267","doi-asserted-by":"crossref","unstructured":"Siponen, M.I., Welin, M., Arrowsmith, C.H., Berglund, H., Bountra, C., Collins, R., Dahlgren, L.G., Edwards, A.M., Flodin, S., and Flores, A. (2009). Crystal structure of Leishmania major S-adenosylhomocysteine hydrolase, doi:10.2210\/pdb3g1u\/pdb.","DOI":"10.2210\/pdb3g1u\/pdb"},{"key":"ref_268","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/j.jmb.2004.08.104","article-title":"Crystal structure of S-adenosyl-l-homocysteine hydrolase from the human malaria parasite Plasmodium falciparum","volume":"343","author":"Tanaka","year":"2004","journal-title":"J. Mol. Biol."},{"key":"ref_269","doi-asserted-by":"crossref","unstructured":"Siponen, M.I., Schutz, P., and Arrowsmith, C.H. (2009). Crystal structure of S-adenosyl homocysteine hydrolase (SAHH) from Trypanosoma brucei, doi:10.2210\/pdb3h9u\/pdb.","DOI":"10.2210\/pdb3h9u\/pdb"},{"key":"ref_270","doi-asserted-by":"crossref","unstructured":"Larson, E.T., Zhang, L., Napuli, A., Mueller, N., Verlinde, C.L.M.J., van Voorhis, W.C., Buckner, F.S., Fan, E., Hol, W.G.J., and Merritt, E.A. (2010). X-ray crystal structure of Seryl-tRNA synthetase from the eukaryotic parasite Trypanosoma brucei, doi:10.2210\/pdb3lsq\/pdb, doi:10.2210\/pdb3lss\/pdb.","DOI":"10.2210\/pdb3lsq\/pdb"},{"key":"ref_271","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1021\/cb200230x","article-title":"Plasmodium falciparum Sir2A preferentially hydrolyzes medium and long chain fatty acyl lysine","volume":"7","author":"Zhu","year":"2012","journal-title":"ACS Chem. Biol."},{"key":"ref_272","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.jmb.2007.07.053","article-title":"Crystal structure of Plasmodium falciparum spermidine synthase in complex with the substrate decarboxylated S-adenosylmethionine and the potent inhibitors 4MCHA and AdoDATO","volume":"373","author":"Dufe","year":"2007","journal-title":"J. Mol. Biol."},{"key":"ref_273","doi-asserted-by":"crossref","unstructured":"Qiu, W., Dong, A., Ren, H., Wu, H., Zhao, Y., Schapira, M., Wasney, G., Vedadi, M., Lew, J., Kozieradzki, I., and Edwards, A.M. (2007). Crystal structure of spermidine synthase from Plasmodium falciparum, doi:10.2210\/pdb2pwp\/pdb.","DOI":"10.2210\/pdb2pwp\/pdb"},{"key":"ref_274","doi-asserted-by":"crossref","unstructured":"Burger, P.B., Williams, M., Reeksting, S.B., Muller, I.B., Al-Karadaghi, S., Briggs, J.M., Joubert, F., Birkholtz, L., and Louw, A.I. (2012). Insights into the design of novel inhibitors against Plasmodium falciparum spermidine synthase using structurally derived binding descriptors, doi:10.2210\/pdb3rie\/pdb.","DOI":"10.2210\/pdb3rie\/pdb"},{"key":"ref_275","doi-asserted-by":"crossref","unstructured":"Bosch, J., Arakaki, T.L., Le Trong, I., Merritt, E.A., and Hol, W.G.J. (2008). Crystal structure of spermidine synthase from Trypanosoma cruzi, doi:10.2210\/pdb3bwc\/pdb.","DOI":"10.2210\/pdb3bwb\/pdb"},{"key":"ref_276","doi-asserted-by":"crossref","first-page":"26838","DOI":"10.1074\/jbc.M111.237099","article-title":"Substrate preferences and catalytic parameters determined by structural characteristics of sterol 14\u03b1-demethylase (CYP51) from Leishmania infantum","volume":"286","author":"Hargrove","year":"2011","journal-title":"J. Biol. Chem."},{"key":"ref_277","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1074\/jbc.M109.067470","article-title":"Crystal structures of Trypanosoma brucei sterol 14\u03b1-demethylase and implications for selective treatment of human infections","volume":"285","author":"Lepesheva","year":"2010","journal-title":"J. Biol. Chem."},{"key":"ref_278","doi-asserted-by":"crossref","unstructured":"Chen, C.K., Leung, S.S., Guilbert, C., Jacobson, M.P., McKerrow, J.H., and Podust, L.M. (2010). Structural characterization of CYP51 from Trypanosoma cruzi and Trypanosoma brucei bound to the antifungal drugs posaconazole and fluconazole. PLoS Negl. Trop. Dis., 4.","DOI":"10.1371\/journal.pntd.0000651"},{"key":"ref_279","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1194\/jlr.M021865","article-title":"Structural complex of sterol 14\u03b1-demethylase (CYP51) with 14\u03b1-methylenecyclopropyl-\u03947-24,25-dihydrolanosterol","volume":"53","author":"Hargrove","year":"2012","journal-title":"J. Lipid Res."},{"key":"ref_280","doi-asserted-by":"crossref","first-page":"4914","DOI":"10.1128\/AAC.06244-11","article-title":"Pharmacological characterization, structural studies, and in vivo activities of anti-Chagas disease lead compounds derived from tipifarnib","volume":"56","author":"Buckner","year":"2012","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_281","doi-asserted-by":"crossref","first-page":"7651","DOI":"10.1021\/jm401067s","article-title":"Rational development of 4-aminopyridyl-based inhibitors targeting Trypanosoma cruzi CYP51 as anti-Chagas agents","volume":"56","author":"Choi","year":"2013","journal-title":"J. Med. Chem."},{"key":"ref_282","doi-asserted-by":"crossref","unstructured":"Hargrove, T.Y., Wawrzak, Z., Waterman, M.R., and Lepesheva, G.I. (2005). CYP51 structure-based VNI scaffold development, doi:10.2210\/pdb4g7g\/pdb.","DOI":"10.2210\/pdb4g7g\/pdb"},{"key":"ref_283","doi-asserted-by":"crossref","first-page":"25582","DOI":"10.1074\/jbc.M110.133215","article-title":"Structural insights into inhibition of sterol 14\u03b1-demethylase in the human pathogen Trypanosoma cruzi","volume":"285","author":"Lepesheva","year":"2010","journal-title":"J. Biol. Chem."},{"key":"ref_284","doi-asserted-by":"crossref","first-page":"2556","DOI":"10.1021\/jm400012e","article-title":"Antitrypanosomal lead discovery: Identification of a ligand-efficient inhibitor of Trypanosoma cruzi CYP51 and parasite growth","volume":"56","author":"Andriani","year":"2013","journal-title":"J. Med. Chem."},{"key":"ref_285","doi-asserted-by":"crossref","first-page":"31602","DOI":"10.1074\/jbc.M113.497990","article-title":"Complexes of Trypanosoma cruzi sterol 14\u03b1-demethylase (CYP51) with two pyridine-based drug candidates for Chagas disease: Structural basis for pathogen selectivity","volume":"288","author":"Hargrove","year":"2013","journal-title":"J. Biol. Chem."},{"key":"ref_286","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1002\/cbic.201402027","article-title":"Expanding the binding envelope of CYP51 inhibitors targeting Trypanosoma cruzi with 4-aminopyridyl-based sulfonamide derivatives","volume":"15","author":"Vieira","year":"2014","journal-title":"ChemBiochem"},{"key":"ref_287","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1021\/ml500010m","article-title":"R-Configuration of 4-aminopyridyl-based inhibitors of CYP51 confers superior efficacy against Trypanosoma cruzi","volume":"5","author":"Choi","year":"2014","journal-title":"ACS Med. Chem. Lett."},{"key":"ref_288","doi-asserted-by":"crossref","first-page":"6989","DOI":"10.1021\/jm500448u","article-title":"4-Aminopyridyl-based CYP51 inhibitors as anti-Trypanosoma cruzi drug leads with improved pharmacokinetic profile and in vivo potency","volume":"57","author":"Calvet","year":"2014","journal-title":"J. Med. Chem."},{"key":"ref_289","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1042\/BJ20130669","article-title":"Crystal structures of SCP2-thiolases of Trypanosomatidae, human pathogens causing widespread tropical diseases: The importance for catalysis of the cysteine of the unique HDCF loop","volume":"455","author":"Harijan","year":"2013","journal-title":"Biochem. J."},{"key":"ref_290","doi-asserted-by":"crossref","unstructured":"Boucher, I.W., Brzozowski, A.M., Brannigan, J.A., Schnick, C., Smith, D.J., Kyes, S.A., and Wilkinson, A.J. (2006). The crystal structure of superoxide dismutase from Plasmodium falciparum. BMC Struct. Biol., 6.","DOI":"10.1186\/1472-6807-6-20"},{"key":"ref_291","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1002\/prot.22412","article-title":"Systematic structural studies of iron superoxide dismutases from human parasites and a statistical coupling analysis of metal binding specificity","volume":"77","author":"Bachega","year":"2009","journal-title":"Proteins"},{"key":"ref_292","doi-asserted-by":"crossref","first-page":"4007","DOI":"10.1038\/sj.emboj.7600861","article-title":"Structural basis for UTP specificity of RNA editing TUTases from Trypanosoma brucei","volume":"24","author":"Deng","year":"2005","journal-title":"EMBO J."},{"key":"ref_293","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/j.jmb.2006.11.065","article-title":"UTP-bound and Apo structures of a minimal RNA uridylyltransferase","volume":"366","author":"Stagno","year":"2007","journal-title":"J. Mol. Biol."},{"key":"ref_294","doi-asserted-by":"crossref","first-page":"14634","DOI":"10.1073\/pnas.0704259104","article-title":"Dual role of the RNA substrate in selectivity and catalysis by terminal uridylyl transferases","volume":"104","author":"Stagno","year":"2007","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_295","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.jmb.2011.12.042","article-title":"Evolutionary walk between (\u03b2\/\u03b1)(8) barrels: Catalytic migration from triosephosphate isomerase to thiamin phosphate synthase","volume":"416","author":"Olvera","year":"2012","journal-title":"J. Mol. Biol."},{"key":"ref_296","doi-asserted-by":"crossref","first-page":"11693","DOI":"10.1073\/pnas.1202593109","article-title":"Leishmania TDR1 structure, a unique trimeric glutathione transferase capable of deglutathionylation and antimonial prodrug activation","volume":"109","author":"Fyfe","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_297","doi-asserted-by":"crossref","first-page":"3446","DOI":"10.1016\/j.jmb.2013.06.037","article-title":"Crystal structure of the Plasmodium falciparum thioredoxin reductase-thioredoxin complex","volume":"425","author":"Jortzik","year":"2013","journal-title":"J. Mol. Biol."},{"key":"ref_298","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1042\/BJ20091880","article-title":"Structural basis for the efficient phosphorylation of AZT-MP (3\u2032-azido-3\u2032-deoxythymidine monophosphate) and dGMP by Plasmodium falciparum type I thymidylate kinase","volume":"428","author":"Whittingham","year":"2010","journal-title":"Biochem. J."},{"key":"ref_299","doi-asserted-by":"crossref","first-page":"10948","DOI":"10.1021\/jm301328h","article-title":"Synthesis and evaluation of \u03b1-thymidine analogues as novel antimalarials","volume":"55","author":"Cui","year":"2012","journal-title":"J. Med. Chem."},{"key":"ref_300","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1042\/BJ20040459","article-title":"Transketolase from Leishmania mexicana has a dual subcellular localization","volume":"382","author":"Veitch","year":"2004","journal-title":"Biochem. J."},{"key":"ref_301","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.bcp.2012.10.006","article-title":"Molecular interaction of artemisinin with translationally controlled tumor protein (TCTP) of Plasmodium falciparum","volume":"85","author":"Eichhorn","year":"2013","journal-title":"Biochem. Pharmacol."},{"key":"ref_302","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/S1097-2765(02)00680-9","article-title":"The crystal structure and mode of action of trans-sialidase, a key enzyme in Trypanosoma cruzi pathogenesis","volume":"10","author":"Buschiazzo","year":"2002","journal-title":"Mol. Cell"},{"key":"ref_303","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/j.str.2004.02.036","article-title":"Structural insights into the catalytic mechanism of Trypanosoma cruzi trans-sialidase","volume":"12","author":"Amaya","year":"2004","journal-title":"Structure"},{"key":"ref_304","doi-asserted-by":"crossref","first-page":"2700","DOI":"10.1002\/anie.200705435","article-title":"A new generation of specific Trypanosoma cruzi trans-sialidase inhibitors","volume":"47","author":"Buchini","year":"2008","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"ref_305","doi-asserted-by":"crossref","unstructured":"Buschiazzo, A., Mui\u00e1, R., Larrieux, N., Pitcovsky, T., Mucci, J., and Campetella, O. (2012). Trypanosoma cruzi trans-sialidase in complex with a neutralizing antibody: Structure\/function studies towards the rational design of inhibitors. PLoS Pathog., 8.","DOI":"10.1371\/journal.ppat.1002474"},{"key":"ref_306","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1093\/protein\/12.3.243","article-title":"Structural and mutagenesis studies of Leishmania triosephosphate isomerase: A point mutation can convert a mesophilic enzyme into a superstable enzyme without losing catalytic power","volume":"12","author":"Williams","year":"1999","journal-title":"Protein Eng."},{"key":"ref_307","doi-asserted-by":"crossref","first-page":"5189","DOI":"10.1046\/j.0014-2956.2001.02452.x","article-title":"Structural determinants for ligand binding and catalysis of triosephosphate isomerase","volume":"268","author":"Kursula","year":"2001","journal-title":"Eur. J. Biochem."},{"key":"ref_308","doi-asserted-by":"crossref","first-page":"9544","DOI":"10.1074\/jbc.M211389200","article-title":"Crystal structure of triosephosphate isomerase complexed with 2-phosphoglycolate at 0.83-\u00c5 resolution","volume":"278","author":"Kursula","year":"2003","journal-title":"J. Biol. Chem."},{"key":"ref_309","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1002\/prot.22701","article-title":"Atomic resolution crystallography of a complex of triosephosphate isomerase with a reaction-intermediate analog: New insight in the proton transfer reaction mechanism","volume":"78","author":"Alahuhta","year":"2010","journal-title":"Proteins"},{"key":"ref_310","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1002\/pro.667","article-title":"High resolution crystal structures of triosephosphate isomerase complexed with its suicide inhibitors: The conformational flexibility of the catalytic glutamate in its closed, liganded active site","volume":"20","author":"Venkatesan","year":"2011","journal-title":"Protein Sci."},{"key":"ref_311","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/S0969-2126(97)00230-X","article-title":"Triosephosphate isomerase from Plasmodium falciparum: The crystal structure provides insights into antimalarial drug design","volume":"5","author":"Velanker","year":"1997","journal-title":"Structure"},{"key":"ref_312","doi-asserted-by":"crossref","first-page":"13178","DOI":"10.1021\/bi025783a","article-title":"Structure of the Plasmodium falciparum triosephosphate isomerase-phosphoglycolate complex in two crystal forms: Characterization of catalytic loop open and closed conformations in the ligand-bound state","volume":"41","author":"Parthasarathy","year":"2002","journal-title":"Biochemistry"},{"key":"ref_313","doi-asserted-by":"crossref","first-page":"1992","DOI":"10.1107\/S0907444902015433","article-title":"Structures of Plasmodium falciparum triosephosphate isomerase complexed to substrate analogues: Observation of the catalytic loop in the open conformation in the ligand-bound state","volume":"58","author":"Parthasarathy","year":"2002","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"ref_314","doi-asserted-by":"crossref","first-page":"52461","DOI":"10.1074\/jbc.M308525200","article-title":"Structure of Plasmodium falciparum triose-phosphate isomerase-2-phosphoglycerate complex at 1.1-\u00c5 resolution","volume":"278","author":"Parthasarathy","year":"2003","journal-title":"J. Biol. Chem."},{"key":"ref_315","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1107\/S0907444909018666","article-title":"Biochemical and structural characterization of residue 96 mutants of Plasmodium falciparum triosephosphate isomerase: Active-site loop conformation, hydration and identification of a dimer-interface ligand-binding site","volume":"65","author":"Gayathri","year":"2009","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"ref_316","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/j.1432-1033.1991.tb15985.x","article-title":"Anion binding at the active site of trypanosomal triosephosphate isomerase. Monohydrogen phosphate does not mimic sulphate","volume":"198","author":"Verlinde","year":"1991","journal-title":"Eur. J. Biochem."},{"key":"ref_317","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1002\/prot.340100105","article-title":"The crystal structure of the \u201copen\u201d and the \u201cclosed\u201d conformation of the flexible loop of trypanosomal triosephosphate isomerase","volume":"10","author":"Wierenga","year":"1991","journal-title":"Proteins"},{"key":"ref_318","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1002\/prot.340100106","article-title":"The adaptability of the active site of trypanosomal triosephosphate isomerase as observed in the crystal structures of three different complexes","volume":"10","author":"Noble","year":"1991","journal-title":"Proteins"},{"key":"ref_319","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1016\/0022-2836(91)90368-G","article-title":"Refined 1.83 \u00c5 structure of trypanosomal triosephosphate isomerase crystallized in the presence of 2.4 M-ammonium sulphate. A comparison with the structure of the trypanosomal triosephosphate isomerase-glycerol-3-phosphate complex","volume":"220","author":"Wierenga","year":"1991","journal-title":"J. Mol. Biol."},{"key":"ref_320","doi-asserted-by":"crossref","first-page":"2709","DOI":"10.1021\/jm00113a007","article-title":"Crystallographic and molecular modeling studies on trypanosomal triosephosphate isomerase: A critical assessment of the predicted and observed structures of the complex with 2-phosphoglycerate","volume":"34","author":"Noble","year":"1991","journal-title":"J. Med. Chem."},{"key":"ref_321","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1002\/prot.340160402","article-title":"Structures of the \u201copen\u201d and \u201cclosed\u201d state of trypanosomal triosephosphate isomerase, as observed in a new crystal form: Implications for the reaction mechanism","volume":"16","author":"Noble","year":"1993","journal-title":"Proteins"},{"key":"ref_322","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1002\/pro.5560030507","article-title":"Comparison of the structures and the crystal contacts of trypanosomal triosephosphate isomerase in four different crystal forms","volume":"3","author":"Kishan","year":"1994","journal-title":"Protein Sci."},{"key":"ref_323","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1093\/protein\/10.2.159","article-title":"Protein engineering with monomeric triosephosphate isomerase (monoTIM): The modelling and structure verification of a seven-residue loop","volume":"10","author":"Thanki","year":"1997","journal-title":"Protein Eng."},{"key":"ref_324","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1002\/1097-0134(20010215)42:3<383::AID-PROT80>3.0.CO;2-G","article-title":"Modeling, mutagenesis, and structural studies on the fully conserved phosphate-binding loop (loop 8) of triosephosphate isomerase: Toward a new substrate specificity","volume":"42","author":"Norledge","year":"2001","journal-title":"Proteins"},{"key":"ref_325","doi-asserted-by":"crossref","first-page":"15483","DOI":"10.1021\/bi061683j","article-title":"Functional role of the conserved active site proline of triosephosphate isomerase","volume":"45","author":"Casteleijn","year":"2006","journal-title":"Biochemistry"},{"key":"ref_326","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1107\/S0907444910025710","article-title":"Crystallographic binding studies with an engineered monomeric variant of triosephosphate isomerase","volume":"66","author":"Salin","year":"2010","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"ref_327","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1006\/jmbi.1998.2094","article-title":"Differences in the intersubunit contacts in triosephosphate isomerase from two closely related pathogenic trypanosomes","volume":"283","author":"Maldonado","year":"1998","journal-title":"J. Mol. Biol."},{"key":"ref_328","doi-asserted-by":"crossref","first-page":"10062","DOI":"10.1073\/pnas.96.18.10062","article-title":"Crystal structure of triosephosphate isomerase from Trypanosoma cruzi in hexane","volume":"96","author":"Gao","year":"1999","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_329","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1016\/j.jmb.2004.06.056","article-title":"Inactivation of triosephosphate isomerase from Trypanosoma cruzi by an agent that perturbs its dimer interface","volume":"341","author":"Costas","year":"2004","journal-title":"J. Mol. Biol."},{"key":"ref_330","doi-asserted-by":"crossref","unstructured":"Olivares-Illana, V., Rodr\u00edguez-Romero, A., Becker, I., Berzunza, M., Garc\u00eda, J., P\u00e9rez-Montfort, R., Cabrera, N., L\u00f3pez-Calahorra, F., de G\u00f3mez-Puyou, M.T., and G\u00f3mez-Puyou, A. (2007). Perturbation of the dimer interface of triosephosphate isomerase and its effect on Trypanosoma cruzi. PLoS Negl. Trop. Dis., 1.","DOI":"10.1371\/journal.pntd.0000001"},{"key":"ref_331","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S0079-6603(08)00407-8","article-title":"The folding pathway of triosephosphate isomerase","volume":"84","year":"2008","journal-title":"Prog. Mol. Biol. Transl. Sci."},{"key":"ref_332","doi-asserted-by":"crossref","unstructured":"Garc\u00eda-Torres, I., Cabrera, N., Torres-Larios, A., Rodr\u00edguez-Bola\u00f1os, M., D\u00edaz-Mazariegos, S., G\u00f3mez-Puyou, A., and Perez-Montfort, R. (2011). Identification of amino acids that account for long-range interactions in two triosephosphate isomerases from pathogenic trypanosomes. PLoS ONE, 6.","DOI":"10.2210\/pdb3q37\/pdb"},{"key":"ref_333","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1002\/prot.24398","article-title":"Different contribution of conserved amino acids to the global properties of triosephosphate isomerases","volume":"82","author":"Aguirre","year":"2014","journal-title":"Proteins"},{"key":"ref_334","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1021\/jm900185q","article-title":"Molecular basis of antimony treatment in leishmaniasis","volume":"52","author":"Baiocco","year":"2009","journal-title":"J. Med. Chem."},{"key":"ref_335","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1021\/ml1002629","article-title":"Inhibitory effect of silver nanoparticles on trypanothione reductase activity and Leishmania infantum proliferation","volume":"2","author":"Baiocco","year":"2011","journal-title":"ACS Med. Chem. Lett."},{"key":"ref_336","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1007\/s00726-011-0997-9","article-title":"A gold-containing drug against parasitic polyamine metabolism: The X-ray structure of trypanothione reductase from Leishmania infantum in complex with auranofin reveals a dual mechanism of enzyme inhibition","volume":"42","author":"Ilari","year":"2012","journal-title":"Amino Acids"},{"key":"ref_337","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1002\/cmdc.201300176","article-title":"Inhibition of Leishmania infantum trypanothione reductase by azole-based compounds: A comparative analysis with its physiological substrate by X-ray crystallography","volume":"8","author":"Baiocco","year":"2013","journal-title":"ChemMedChem"},{"key":"ref_338","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.molbiopara.2009.09.002","article-title":"Comparative structural, kinetic and inhibitor studies of Trypanosoma brucei trypanothione reductase with T. cruzi","volume":"169","author":"Jones","year":"2010","journal-title":"Mol. Biochem. Parasitol."},{"key":"ref_339","doi-asserted-by":"crossref","first-page":"6514","DOI":"10.1021\/jm200312v","article-title":"Dihydroquinazolines as a novel class of Trypanosoma brucei trypanothione reductase inhibitors: Discovery, synthesis, and characterization of their binding mode by protein crystallography","volume":"54","author":"Patterson","year":"2011","journal-title":"J. Med. Chem."},{"key":"ref_340","doi-asserted-by":"crossref","first-page":"1880","DOI":"10.1002\/cmdc.201402032","article-title":"Binding to large enzyme pockets: Small-molecule inhibitors of trypanothione reductase","volume":"9","author":"Persch","year":"2014","journal-title":"ChemMedChem"},{"key":"ref_341","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1002\/prot.340180208","article-title":"The structure of Trypanosoma cruzi trypanothione reductase in the oxidized and NADPH reduced state","volume":"18","author":"Lantwin","year":"1994","journal-title":"Proteins"},{"key":"ref_342","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1002\/pro.5560050107","article-title":"The crystal structure of trypanothione reductase from the human pathogen Trypanosoma cruzi at 2.3 \u00c5 resolution","volume":"5","author":"Zhang","year":"1996","journal-title":"Protein Sci."},{"key":"ref_343","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0969-2126(99)80011-2","article-title":"Crystal structure of Trypanosoma cruzi trypanothione reductase in complex with trypanothione, and the structure-based discovery of new natural product inhibitors","volume":"7","author":"Bond","year":"1999","journal-title":"Structure"},{"key":"ref_344","doi-asserted-by":"crossref","first-page":"29493","DOI":"10.1074\/jbc.M403187200","article-title":"Two interacting binding sites for quinacrine derivatives in the active site of trypanothione reductase: A template for drug design","volume":"279","author":"Saravanamuthu","year":"2004","journal-title":"J. Biol. Chem."},{"key":"ref_345","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1042\/BJ20080889","article-title":"Structural and mechanistic insights into type II trypanosomatid tryparedoxin-dependent peroxidases","volume":"414","author":"Alphey","year":"2008","journal-title":"Biochem. J."},{"key":"ref_346","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.jsb.2004.12.005","article-title":"Crystal structure of the tryparedoxin peroxidase from the human parasite Trypanosoma cruzi","volume":"150","author":"Pizarro","year":"2005","journal-title":"J. Struct. Biol."},{"key":"ref_347","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.molbiopara.2013.04.007","article-title":"Crystal structures of Plasmodium falciparum cytosolic tryptophanyl-tRNA synthetase and its potential as a target for structure-guided drug design","volume":"189","author":"Koh","year":"2013","journal-title":"Mol. Biochem. Parasitol."},{"key":"ref_348","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.molbiopara.2011.01.003","article-title":"Crystal structures of three protozoan homologs of tryptophanyl-tRNA synthetase","volume":"177","author":"Merritt","year":"2011","journal-title":"Mol. Biochem. Parasitol."},{"key":"ref_349","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.jmb.2011.03.026","article-title":"The double-length tyrosyl-tRNA synthetase from the eukaryote Leishmania major forms an intrinsically asymmetric pseudo-dimer","volume":"409","author":"Larson","year":"2011","journal-title":"J. Mol. Biol."},{"key":"ref_350","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1038\/ncomms1522","article-title":"Malaria parasite tyrosyl-tRNA synthetase secretion triggers pro-inflammatory responses","volume":"2","author":"Bhatt","year":"2011","journal-title":"Nat. Commun."},{"key":"ref_351","doi-asserted-by":"crossref","first-page":"6857","DOI":"10.1074\/jbc.M109.072405","article-title":"Characterization and structural studies of the Plasmodium falciparum ubiquitin and Nedd8 hydrolase UCHL3","volume":"285","author":"Weihofen","year":"2010","journal-title":"J. Biol. Chem."},{"key":"ref_352","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0166-6851(02)00243-8","article-title":"High-resolution crystal structure of Trypanosoma brucei UDP-galactose 4\u2032-epimerase: A potential target for structure-based development of novel trypanocides","volume":"126","author":"Shaw","year":"2003","journal-title":"Mol. Biochem. Parasitol."},{"key":"ref_353","doi-asserted-by":"crossref","first-page":"4968","DOI":"10.1021\/bi300498c","article-title":"Crystal structures of Trypanosoma cruzi UDP-galactopyranose mutase implicate flexibility of the histidine loop in enzyme activation","volume":"51","author":"Dhatwalia","year":"2012","journal-title":"Biochemistry"},{"key":"ref_354","doi-asserted-by":"crossref","first-page":"2976","DOI":"10.1021\/cs4007777","article-title":"Catalytic mechanism and allosteric regulation of UDP-glucose pyrophosphorylase from Leishmania major","volume":"3","author":"Cramer","year":"2013","journal-title":"ACS Catal."},{"key":"ref_355","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1021\/cb400411x","article-title":"A novel allosteric inhibitor of the uridine diphosphate N-acetylglucosamine pyrophosphorylase from Trypanosoma brucei","volume":"8","author":"Urbaniak","year":"2013","journal-title":"ACS Chem. Biol."},{"key":"ref_356","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1016\/j.jmb.2010.01.013","article-title":"The crystal structure and activity of a putative trypanosomal nucleoside phosphorylase reveal it to be a homodimeric uridine phosphorylase","volume":"396","author":"Larson","year":"2010","journal-title":"J. Mol. Biol."},{"key":"ref_357","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1002\/jmr.2471","article-title":"Improvements, trands, and new ideas in molecular docking: 2012\u20132013 in review","volume":"28","author":"Yuriev","year":"2015","journal-title":"J. Mol. Recognit."},{"key":"ref_358","doi-asserted-by":"crossref","first-page":"13384","DOI":"10.3390\/molecules200713384","article-title":"Molecular docking and structure-based drug design strategies","volume":"20","author":"Ferreira","year":"2015","journal-title":"Molecules"},{"key":"ref_359","unstructured":"Tran, Q.N., and Hamid, A.R. (2015). Emerging Trends in Computational Biology, Bioinformatics, and Systems Biology, Elsevier."},{"key":"ref_360","first-page":"1","article-title":"Molecular docking as a popular tool in drug design, an in silico travel","volume":"9","author":"Brysbaert","year":"2016","journal-title":"Adv. Appl. Bioinform. Chem."},{"key":"ref_361","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1002\/jmr.1077","article-title":"Challenges and advances in computational docking: 2009 in review","volume":"24","author":"Yuriev","year":"2011","journal-title":"J. Mol. Recognit."},{"key":"ref_362","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1002\/jmr.2266","article-title":"Latest developments in molecular docking: 2010\u20132011 in review","volume":"26","author":"Yuriev","year":"2013","journal-title":"J. Mol. Recognit."},{"key":"ref_363","doi-asserted-by":"crossref","first-page":"4103","DOI":"10.1021\/acs.jmedchem.5b02008","article-title":"Docking screens for novel ligands conferring new biology","volume":"59","author":"Irwin","year":"2016","journal-title":"J. Med. Chem."},{"key":"ref_364","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/s12539-011-0101-x","article-title":"Screening natural products database for identification of potential antileishmanial chemotherapeutic agents","volume":"3","author":"Venkatesan","year":"2011","journal-title":"Interdiscip. Sci."},{"key":"ref_365","doi-asserted-by":"crossref","unstructured":"Herrmann, F.C., and Schmidt, T.J. (2013). In silico screening of natural product databases reveals new potential leads against neglected diseases. Planta Med., 79.","DOI":"10.1055\/s-0033-1351916"},{"key":"ref_366","unstructured":"Buckingham, J. (2016). Dictionary of Natural Products on DVD, CRC Press. (Ed.)."},{"key":"ref_367","unstructured":"Napralert Natural Products Alert. Available online: http:\/\/napralert.org."},{"key":"ref_368","unstructured":"ZINC12. Available online: http:\/\/zinc.docking.org\/browse\/catalogs\/natural-products."},{"key":"ref_369","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.1002\/jcc.21256","article-title":"Autodock4 and AutoDockTools4: Automated docking with selective receptor flexiblity","volume":"16","author":"Morris","year":"2009","journal-title":"J. Comput. Chem."},{"key":"ref_370","doi-asserted-by":"crossref","first-page":"3315","DOI":"10.1021\/jm051197e","article-title":"MolDock: A new technique for high-accuracy molecular docking","volume":"49","author":"Thomsen","year":"2006","journal-title":"J. Med. Chem."},{"key":"ref_371","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1021\/jm0306430","article-title":"Glide: A new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy","volume":"47","author":"Friesner","year":"2004","journal-title":"J. Med. Chem."},{"key":"ref_372","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/jcc.21334","article-title":"AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading","volume":"31","author":"Trott","year":"2010","journal-title":"J. Comput. Chem."},{"key":"ref_373","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/s10822-007-9114-2","article-title":"Surflex-Dock 2.1: Robust performance from ligand energetic modeling, ring, flexibility, and knowledge-based search","volume":"21","author":"Jain","year":"2007","journal-title":"J. Comput. Aided Mol. Des."},{"key":"ref_374","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.4155\/fmc.13.114","article-title":"Interactions of antiparasitic alkaloids with Leishmania protein targets: A molecular docking analysis","volume":"5","author":"Ogungbe","year":"2013","journal-title":"Future Med. Chem."},{"key":"ref_375","doi-asserted-by":"crossref","first-page":"7761","DOI":"10.3390\/molecules18077761","article-title":"In-silico Leishmania target selectivity of antiparasitic terpenoids","volume":"18","author":"Ogungbe","year":"2013","journal-title":"Molecules"},{"key":"ref_376","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1007\/s00044-013-0654-9","article-title":"In silico docking studies of bioactive natural plant products as putative DHFR antagonists","volume":"23","author":"Kumar","year":"2014","journal-title":"Med. Chem. Res."},{"key":"ref_377","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.jmgm.2013.12.010","article-title":"Antileishmanial phytochemical phenolics: Molecular docking to potential protein targets","volume":"48","author":"Ogungbe","year":"2014","journal-title":"J. Mol. Graph. Model."},{"key":"ref_378","doi-asserted-by":"crossref","first-page":"5550","DOI":"10.3390\/molecules19055550","article-title":"In-silico analyses of sesquiterpene-related compounds on selected Leishmania enzyme-based targets","volume":"19","author":"Bernal","year":"2014","journal-title":"Molecules"},{"key":"ref_379","doi-asserted-by":"crossref","unstructured":"Setzer, W.N., and Ogungbe, I.V. (2012). In-silico investigation of antitrypanosomal phytochemicals from Nigerian medicinal plants. PLoS Negl. Trop. Dis., 6.","DOI":"10.1371\/journal.pntd.0001727"},{"key":"ref_380","doi-asserted-by":"crossref","first-page":"205","DOI":"10.2174\/157488470903140806114147","article-title":"An in-silico investigation of anti-Chagas phytochemicals","volume":"9","author":"McCulley","year":"2014","journal-title":"Curr. Clin. Pharmacol."},{"key":"ref_381","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.parint.2016.01.001","article-title":"Oleanolic acid (OA) as an antileishmanial agent: Biological evaluation and in silico mechanistic insights","volume":"65","author":"Melo","year":"2016","journal-title":"Parasitol. Int."},{"key":"ref_382","doi-asserted-by":"crossref","unstructured":"Dos Reis, M.B.G., Manjolin, L.C., Maquiaveli, C.D.C., Santos-Filho, O.A., and da Silva, E.R. (2013). Inhibition of Leishmania (Leishmania) amazonensis and rat arginases by green tea EGCG, (+)-catechin and (2)-epicatechin: A comparative structural analysis of enzyme-inhibitor interactions. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0078387"},{"key":"ref_383","first-page":"41","article-title":"Identification of novel inhibitor of trypanothione synthase from two Leishmania species: Comparative in silico analysis","volume":"2","author":"Venkatesan","year":"2011","journal-title":"J. Protein Proteom."},{"key":"ref_384","doi-asserted-by":"crossref","first-page":"S77","DOI":"10.1007\/s00436-002-0771-8","article-title":"Parasite-specific trypanothione reductase as a drug target molecule","volume":"90","author":"Inhoff","year":"2003","journal-title":"Parasitol. Res."},{"key":"ref_385","first-page":"133","article-title":"Molecular docking based inhibition of trypanothione reductase activity of taxifolin novel target for antileishmanial activity","volume":"2","author":"Gundampati","year":"2012","journal-title":"J. Appl. Pharmaceut. Sci."},{"key":"ref_386","first-page":"917","article-title":"Computational and investigative study of flavonoids against Trypanosoma cruzi and Leishmania spp.","volume":"10","author":"Ribeiro","year":"2015","journal-title":"Nat. Prod. Commun."},{"key":"ref_387","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0169-409X(00)00129-0","article-title":"Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings","volume":"46","author":"Lipinski","year":"2001","journal-title":"Adv. Drug Deliv. Rev."},{"key":"ref_388","first-page":"40","article-title":"Molecular docking study on the interaction between trypanothione reductase and mangiferin for antileishmanial activity","volume":"8","author":"Gundampati","year":"2013","journal-title":"Bangladesh J. Pharmacol."},{"key":"ref_389","unstructured":"Chauhan, R. (2014). In Silico Approach towards Finding Inhibitory Effect of Phytochemicals on Trypanothione Reductase in Leishmania donovani. [Master\u2019s Thesis, National Institute of Technology]."},{"key":"ref_390","doi-asserted-by":"crossref","first-page":"963658","DOI":"10.1100\/2012\/963658","article-title":"Footprinting of inhibitor interactions of in silico identified inhibitors of trypanothione reductase of Leishmania parasite","volume":"2012","author":"Venkatesan","year":"2012","journal-title":"Sci. World J."},{"key":"ref_391","first-page":"1189","article-title":"Inhibitory effect of steroidal alkaloids on drug transport and multidrug resistance in human cancer cells","volume":"21","author":"Lavie","year":"2001","journal-title":"Anticancer Res."},{"key":"ref_392","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1017\/S0031182012000522","article-title":"Tomatidine promotes the inhibition of 24-alkylated sterol biosynthesis and mitochondrial dysfunction in Leishmania amazonensis promastigotes","volume":"139","author":"Medina","year":"2012","journal-title":"Parasitology"},{"key":"ref_393","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.3390\/molecules14041513","article-title":"Comparative molecular docking of antitrypanosomal natural products into multiple Trypanosoma brucei drug targets","volume":"14","author":"Ogungbe","year":"2009","journal-title":"Molecules"},{"key":"ref_394","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1039\/c0np00069h","article-title":"Natural products and Chagas\u2019 disease: A review of plant compounds studied for activity against Trypanosoma cruzi","volume":"28","author":"Izumi","year":"2011","journal-title":"Nat. Prod. Rep."},{"key":"ref_395","first-page":"57","article-title":"Molecular docking and binding mode analysis of plant alkaloids as in vitro and in silico inhibitors of trypanothione reductase from Trypanosoma cruzi","volume":"11","author":"Cordell","year":"2016","journal-title":"Nat. Prod. Commun."},{"key":"ref_396","first-page":"247","article-title":"In silico screening to elucidate the therapeutic potentials of asparagamine A","volume":"6","author":"Asthana","year":"2014","journal-title":"Int. J. Pharm. Pharmaceut. Sci."},{"key":"ref_397","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1007\/s00044-014-1122-x","article-title":"Docking-based screening of natural product database in quest for dual site inhibitors of Trypanosoma cruzi trypanothione reductase (TcTR)","volume":"24","author":"Saha","year":"2015","journal-title":"Med. Chem. Res."},{"key":"ref_398","doi-asserted-by":"crossref","first-page":"5065","DOI":"10.1007\/s00894-012-1508-y","article-title":"Leishmania donovani pteridine reductase 1: Comparative protein modeling and protein-ligand interaction studies of the leishmanicidal constituents isolated from the fruits of Piper longum","volume":"18","author":"Sahi","year":"2012","journal-title":"J. Mol. Model."},{"key":"ref_399","doi-asserted-by":"crossref","first-page":"16154","DOI":"10.3390\/molecules200916154","article-title":"In silico identification and in vitro activity of novel natural inhibitors of Trypanosoma brucei glyceraldehyde-3-phosphate dehydrogenase","volume":"20","author":"Herrmann","year":"2015","journal-title":"Molecules"},{"key":"ref_400","doi-asserted-by":"crossref","first-page":"253","DOI":"10.2174\/138955751503150312141854","article-title":"In-silico analyses of natural products on Leishmania enzyme targets","volume":"15","author":"Scotti","year":"2015","journal-title":"Mini Rev. Med. Chem."},{"key":"ref_401","doi-asserted-by":"crossref","first-page":"62","DOI":"10.3126\/ijasbt.v1i2.8077","article-title":"Comparative genomic studies and in-silico strategies on Leishmania braziliensis, Leishmania infantum and Leishmania major: Conserved features, putative functions and potential drug target","volume":"1","author":"Rakesh","year":"2013","journal-title":"Int. J. Appl. Sci. Biotechnol."},{"key":"ref_402","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.actatropica.2012.01.001","article-title":"Anti-Trypanosoma cruzi activity of nicotinamide","volume":"122","author":"Soares","year":"2012","journal-title":"Acta Trop."},{"key":"ref_403","doi-asserted-by":"crossref","unstructured":"Sacconnay, L., Angleviel, M., Randazzo, G.M., Queiroz, M.M.F., Queiroz, E.F., Wolfender, J.L., Carrupt, P.A., and Nurisso, A. (2014). Computational studies on sirtuins from Trypansomoma cruzi: Structures, conformations and interactions with phytochemicals. PLoS Negl. Trop. Dis., 8.","DOI":"10.1371\/journal.pntd.0002689"},{"key":"ref_404","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/0166-6851(83)90053-1","article-title":"Purine metabolism in Leishmania donovani amastigotes and promastigotes","volume":"9","author":"Looker","year":"1983","journal-title":"Mol. Biochem. Parasitol."},{"key":"ref_405","doi-asserted-by":"crossref","first-page":"609289","DOI":"10.1155\/2013\/609289","article-title":"Computational elucidation of structural basis for ligand binding with Leishmania donovani adenosine kinase","volume":"2013","author":"Kar","year":"2013","journal-title":"BioMed Res. Int."},{"key":"ref_406","doi-asserted-by":"crossref","unstructured":"Chakrabarti, R., Rawat, P.S., Cooke, B.M., Coppel, R.L., and Patankar, S. (2013). Cellular effects of curcumin on Plasmodium falciparum include disruption of microtubules. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0057302"},{"key":"ref_407","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.meegid.2008.02.002","article-title":"Diversity of the sarco\/endoplasmic reticulum Ca2+-ATPase orthologue of Plasmodium falciparum (PfATP6)","volume":"8","author":"Veiga","year":"2008","journal-title":"Infect. Genet. Evol."},{"key":"ref_408","doi-asserted-by":"crossref","first-page":"2994","DOI":"10.1016\/j.bmcl.2005.04.041","article-title":"Three-dimensional structure of Plasmodium falciparum Ca2+-ATPase (PfATP6) and docking of artemisinin derivatives to PfATP6","volume":"15","author":"Jung","year":"2005","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"ref_409","doi-asserted-by":"crossref","first-page":"2453","DOI":"10.1016\/j.bmcl.2009.03.060","article-title":"Interactions of curcumin with the PfATP6 model and the implications for its antimalarial mechanism","volume":"19","author":"Ji","year":"2009","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"ref_410","first-page":"182","article-title":"(Inhibition of P. falciparum PfATP6 by curcumin and its derivatives: A bioinformatics study","volume":"58","author":"Shukla","year":"2012","journal-title":"Cell. Mol. Biol."},{"key":"ref_411","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1002\/cmdc.200900200","article-title":"Docking studies of structurally diverse antimalarial drugs targeting PfATP6: No correlation between in silico binding affinity and in vitro antimalarial activity","volume":"4","author":"Stigliani","year":"2009","journal-title":"ChemMedChem"},{"key":"ref_412","doi-asserted-by":"crossref","first-page":"6219","DOI":"10.1021\/bi049892w","article-title":"Comparative structural analysis and kinetic properties of lactate dehydrogenases from the four species of human malarial parasites","volume":"43","author":"Brown","year":"2004","journal-title":"Biochemistry"},{"key":"ref_413","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.proenv.2013.02.028","article-title":"Tea leaves extracted as anti-malaria based on molecular docking PLANTS","volume":"17","author":"Tegar","year":"2013","journal-title":"Proc. Environ. Sci."},{"key":"ref_414","doi-asserted-by":"crossref","unstructured":"Kalani, K., Agarwal, J., Alam, S., Khan, F., Pal, A., and Srivastava, S.K. (2013). In silico and in vivo anti-malarial studies of 18\u03b2-glycyrrhetinic acid from Glychrrhiza glabra. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0074761"},{"key":"ref_415","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1021\/np400083k","article-title":"Potential of lichen secondary metabolites against Plasmodium liver stage parasites with FAS-II as the potential target","volume":"76","author":"Lauinger","year":"2013","journal-title":"J. Nat. Prod."},{"key":"ref_416","doi-asserted-by":"crossref","first-page":"6053","DOI":"10.1016\/j.bmc.2014.09.002","article-title":"Celastrol inhibits Plasmodium falciparum enoyl-acyl carrier protein reductase","volume":"22","author":"Tallorin","year":"2014","journal-title":"Bioorg. Med. Chem."},{"key":"ref_417","doi-asserted-by":"crossref","first-page":"245","DOI":"10.2174\/1573409911666151030102113","article-title":"Combined 3D-QSAR and molecular docking study for identification of diverse natural products as potent Pf ENR inhibitors","volume":"11","author":"Wadhwa","year":"2015","journal-title":"Curr. Comput. Aided Drug Des."},{"key":"ref_418","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s12539-015-0269-6","article-title":"In silico elucidation and inhibition studies of selected phytoligands against mitogen-activated protein kinases of protozoan parasites","volume":"8","author":"Gupta","year":"2016","journal-title":"Inderdiscip. Sci. Comput. Life Sci."},{"key":"ref_419","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.2174\/092986712799945021","article-title":"Molecular property filters describing pharmacokinetics and drug binding","volume":"19","author":"Maran","year":"2012","journal-title":"Curr. Med. Chem."},{"key":"ref_420","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.addr.2015.01.009","article-title":"The application of in silico drug-likeness predictions in pharmaceutical research","volume":"86","author":"Tian","year":"2015","journal-title":"Adv. Drug Deliv. Rev."},{"key":"ref_421","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1517\/17425255.4.6.759","article-title":"Structure-ADME relationship: Still a long way to go?","volume":"4","author":"Hou","year":"2008","journal-title":"Expert. Opin. Drug Metab. Toxicol."},{"key":"ref_422","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.taap.2009.08.022","article-title":"In silico toxicology for the pharmaceutical sciences","volume":"241","author":"Valerio","year":"2009","journal-title":"Toxicol. Appl. Pharmacol."}],"container-title":["Molecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1420-3049\/21\/10\/1389\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T19:33:26Z","timestamp":1760211206000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1420-3049\/21\/10\/1389"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10,19]]},"references-count":422,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2016,10]]}},"alternative-id":["molecules21101389"],"URL":"https:\/\/doi.org\/10.3390\/molecules21101389","relation":{},"ISSN":["1420-3049"],"issn-type":[{"value":"1420-3049","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,10,19]]}}}